<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">F1000Res</journal-id>
<journal-id journal-id-type="iso-abbrev">F1000Res</journal-id>
<journal-id journal-id-type="pmc">F1000Research</journal-id>
<journal-title-group>
<journal-title>F1000Research</journal-title>
</journal-title-group>
<issn pub-type="epub">2046-1402</issn>
<publisher>
<publisher-name>F1000 Research Limited</publisher-name>
<publisher-loc>London, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32089836</article-id>
<article-id pub-id-type="pmc">7014579</article-id>
<article-id pub-id-type="doi">10.12688/f1000research.20904.1</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epigenetic regulation of oligodendrocyte myelination in developmental disorders and neurodegenerative diseases</article-title>
<fn-group content-type="pub-status">
<fn>
<p>[version 1; peer review: 2 approved]</p>
</fn>
</fn-group>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Berry</surname>
<given-names>Kalen</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data Curation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing – Original Draft Preparation</role>
<role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Jiajia</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data Curation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Q. Richard</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data Curation</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6846-9014</contrib-id>
<xref ref-type="corresp" rid="c1">a</xref>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<aff id="a1">
<label>1</label>Department of Pediatrics, Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 45229, USA</aff>
</contrib-group>
<author-notes>
<corresp id="c1">
<label>a</label>
<email xlink:href="mailto:richard.lu@cchmc.org">richard.lu@cchmc.org</email>
</corresp>
<fn fn-type="COI-statement">
<p>No competing interests were disclosed.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>9</volume>
<elocation-id>F1000 Faculty Rev-105</elocation-id>
<history>
<date date-type="accepted">
<day>30</day>
<month>1</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © 2020 Berry K et al.</copyright-statement>
<copyright-year>2020</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="f1000research-9-23002.pdf"></self-uri>
<abstract>
<p>Oligodendrocytes are the critical cell types giving rise to the myelin nerve sheath enabling efficient nerve transmission in the central nervous system (CNS). Oligodendrocyte precursor cells differentiate into mature oligodendrocytes and are maintained throughout life. Deficits in the generation, proliferation, or differentiation of these cells or their maintenance have been linked to neurological disorders ranging from developmental disorders to neurodegenerative diseases and limit repair after CNS injury. Understanding the regulation of these processes is critical for achieving proper myelination during development, preventing disease, or recovering from injury. Many of the key factors underlying these processes are epigenetic regulators that enable the fine tuning or reprogramming of gene expression during development and regeneration in response to changes in the local microenvironment. These include chromatin remodelers, histone-modifying enzymes, covalent modifiers of DNA methylation, and RNA modification–mediated mechanisms. In this review, we will discuss the key components in each of these classes which are responsible for generating and maintaining oligodendrocyte myelination as well as potential targeted approaches to stimulate the regenerative program in developmental disorders and neurodegenerative diseases.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>epigenetics</kwd>
<kwd>developmental disorders</kwd>
<kwd>neurodegenerative disease</kwd>
<kwd>oligodendrocyte</kwd>
<kwd>myelination</kwd>
<kwd>myelin repair</kwd>
<kwd>multiple sclerosis</kwd>
<kwd>chromatin remodelers</kwd>
<kwd>histone-modifying enzymes</kwd>
<kwd>DNA methylation</kwd>
<kwd>RNA modification</kwd>
</kwd-group>
<funding-group>
<award-group id="fund-1" xlink:href="http://dx.doi.org/10.13039/100000890">
<funding-source>National Multiple Sclerosis Society</funding-source>
<award-id>NMSS-1508</award-id>
</award-group>
<award-group id="fund-2" xlink:href="http://dx.doi.org/10.13039/100000065">
<funding-source>US National Institutes of Health</funding-source>
<award-id>R01NS072427</award-id>
<award-id>R01NS075243</award-id>
</award-group>
<funding-statement>This study was funded in part by grants from the US National Institutes of Health (R01NS072427 and R01NS075243 to QRL) and the National Multiple Sclerosis Society (NMSS-1508 to QRL).</funding-statement>
<funding-statement>
<italic>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</italic>
</funding-statement>
</funding-group>
</article-meta>
<notes>
<sec sec-type="editor-note">
<title>Editorial Note on the Review Process</title>
<p>
<ext-link ext-link-type="uri" xlink:href="http://f1000research.com/browse/f1000-faculty-reviews">F1000 Faculty Reviews</ext-link> are commissioned from members of the prestigious
<ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/thefaculty">F1000 Faculty</ext-link> and are edited as a service to readers. In order to make these reviews as comprehensive and accessible as possible, the referees provide input before publication and only the final, revised version is published. The referees who approved the final version are listed with their names and affiliations but without their reports on earlier versions (any comments will already have been addressed in the published version).</p>
<p>The referees who approved this article are: </p>
<list list-content="reviewer-list" list-type="simple">
<list-item>
<p>
<named-content content-type="reviewer-name">Maria P Abbracchio</named-content>, Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy
<fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn>
</p>
</list-item>
<list-item>
<p>
<named-content content-type="reviewer-name">Davide Marangon</named-content>, Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy
<fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn>
</p>
</list-item>
<list-item>
<p>
<named-content content-type="reviewer-name">Robert H Miller</named-content>, Department of Anatomy and Regenerative Biology, George Washington University School of Medicine and Health Sciences, Washington, DC, USA
<fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn>
</p>
</list-item>
</list>
</sec>
</notes>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Oligodendrocytes are the specialized glial cells of the central nervous system (CNS) that produce the myelin sheaths surrounding axons and enabling salutatory conduction as well as providing metabolic support to axons
<sup><xref ref-type="bibr" rid="ref-1">1</xref></sup>. Defects in the myelination process have been associated with developmental disorders such as autism
<sup><xref ref-type="bibr" rid="ref-2">2</xref>–
<xref ref-type="bibr" rid="ref-5">5</xref></sup> and coloboma, heart disease, atresia choanae, retarded growth and development, genital hypoplasia, and ear abnormalities (CHARGE) syndrome
<sup><xref ref-type="bibr" rid="ref-6">6</xref>,
<xref ref-type="bibr" rid="ref-7">7</xref></sup> as well as neurodegenerative diseases such as the demyelinating disease multiple sclerosis (MS) and various leukodystrophies
<sup><xref ref-type="bibr" rid="ref-8">8</xref></sup>. The late-onset neurodegenerative diseases may also stem from subtle dysregulation of early developmental processes. In addition, dysregulation of the processes controlling proliferation and differentiation in the oligodendrocyte lineage has been linked to the development of various brain cancers
<sup><xref ref-type="bibr" rid="ref-9">9</xref></sup>. Understanding developmental myelination and remyelination processes will have impacts for the development of treatments to improve functional recovery after injury or disease
<sup><xref ref-type="bibr" rid="ref-10">10</xref>–
<xref ref-type="bibr" rid="ref-13">13</xref></sup>.</p>
<p>The oligodendrocyte lineage originates from multi-potent neural progenitor cells (NPCs). Early NPC divisions result predominantly in neurons before switching to a primarily glial progeny later in development
<sup><xref ref-type="bibr" rid="ref-14">14</xref>–
<xref ref-type="bibr" rid="ref-16">16</xref></sup>. First, NPCs become primitive oligodendrocyte progenitor cells (pri-OPCs or pre-OPCs) expressing Olig1/2, then committed OPCs (PDGFRα
<sup>+</sup>/NG2
<sup><italic>+</italic></sup>), which persist in the CNS throughout life
<sup><xref ref-type="bibr" rid="ref-17">17</xref></sup>. OPCs can further proliferate and differentiate into mature myelinating oligodendrocytes
<sup><xref ref-type="bibr" rid="ref-18">18</xref>–
<xref ref-type="bibr" rid="ref-21">21</xref></sup>. The transition into each of these stages requires the coordination of intrinsic and extra-cellular cues where transcriptional regulatory events are closely interconnected and function together to safeguard the oligodendrocyte identity and prevent alternative cell fates such as astrocytes or neurons (
<xref ref-type="fig" rid="f1">Figure 1A</xref>).</p>
<fig fig-type="figure" id="f1" orientation="portrait" position="anchor">
<label>Figure 1. </label>
<caption>
<title>Differentiation of progenitor cells is a highly choreographed process.</title>
<p>(
<bold>A</bold>) A diagram depicts an epigenetic landscape of cellular fate decision-making during oligodendrocyte development from neural progenitor cells. Beginning with neural progenitors, cell differentiation occurs along multiple potential pathways with cells taking on neuronal, astrocyte, or oligodendrocyte lineages. This differentiation from a common progenitor population involves the fine tuning of gene expression and turning on and off of lineage-specific genes and their epigenetic regulators. (
<bold>B</bold>) Many modulators of gene expression are through epigenetic mechanisms, which alter gene expression on the basis of local environmental factors. These mediators include covalent modifications to DNA or histones, RNA-mediated regulation of gene expression, or the enzymes responsible for mediating the effects of these modifications. BRG1, Brahma-related 1; CHD, chromodomain helicase DNA-binding; cOPC, committed oligodendrocyte progenitor cell; DNMT, DNA methyltransferase; HAT, histone acetyltransferase; HDAC, histone deacetylase; OL, oligodendrocyte; pri-OPC, primitive oligodendrocyte progenitor cell; TET, ten-eleven translocation.</p>
</caption>
<graphic xlink:href="f1000research-9-23002-g0000"></graphic>
</fig>
<p>The oligodendrocyte lineage is highly responsive to environmental cues. For example, activity or experience can promote myelination of axons by newly formed oligodendrocytes and even induce the proliferation of OPCs
<sup><xref ref-type="bibr" rid="ref-22">22</xref>–
<xref ref-type="bibr" rid="ref-29">29</xref></sup>. Additionally, there exist critical periods during oligodendrocyte development and myelination
<sup><xref ref-type="bibr" rid="ref-30">30</xref>,
<xref ref-type="bibr" rid="ref-31">31</xref></sup> when oligodendrocytes are highly receptive and adaptive to environmental cues such as neuronal activity
<sup><xref ref-type="bibr" rid="ref-32">32</xref></sup>. The plasticity of myelinating oligodendrocytes and adaptive myelination are important for normal neural circuit function and cognition
<sup><xref ref-type="bibr" rid="ref-33">33</xref></sup>. Epigenetic regulation is likely the process through which the effects of these kinds of stimuli are carried out. At present, how epigenetic mechanisms mediate the environmental cues for oligodendrocyte myelination and remyelination remains poorly defined.</p>
<p>In recent years, the importance of epigenetic mechanisms and their non-genetic regulation of gene expression and cell states has been increasingly recognized
<sup><xref ref-type="bibr" rid="ref-18">18</xref>,
<xref ref-type="bibr" rid="ref-20">20</xref>,
<xref ref-type="bibr" rid="ref-34">34</xref>,
<xref ref-type="bibr" rid="ref-35">35</xref></sup> (
<xref ref-type="table" rid="T1">Table 1</xref>). Epigenetic regulation of gene expression occurs through a variety of mechanisms, including covalent modifications of chromatin to regulate stearic access to DNA, ATP-dependent nucleosome remodeling, DNA methylation, non-coding RNAs, and RNA modifications
<sup><xref ref-type="bibr" rid="ref-21">21</xref>,
<xref ref-type="bibr" rid="ref-78">78</xref></sup>. All of these processes can modulate large-scale genetic programs to alter and maintain cell states during oligodendrocyte progenitor proliferation and maturation (
<xref ref-type="fig" rid="f1">Figure 1B</xref>). Epigenetic modifications are often reversible and provide the necessary plasticity for progenitor cells to respond to environmental cues. Such pathways are amenable to pharmacological intervention and could be targeted to promote myelin growth or repair.</p>
<table-wrap id="T1" orientation="portrait" position="anchor">
<label>Table 1. </label>
<caption>
<title>Epigenetic pathways in oligodendrocyte development and myelination.</title>
</caption>
<table content-type="article-table" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Epigenetic regulators</th>
<th align="left" colspan="1" rowspan="1">Component</th>
<th align="left" colspan="1" rowspan="1">Description</th>
<th align="left" colspan="1" rowspan="1">Function in oligodendrocytes</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="3" valign="top">
<bold>ATP-dependent</bold>
<break></break>
<bold>chromatin remodelers</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">BRG1 (also known as
<break></break>Smarca4)</td>
<td align="left" colspan="1" rowspan="1" valign="top">A key helicase subunit of
<break></break>the SWI/SNF Family</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stage-dependent promotion of OPC differentiation
<break></break>but not required for OPC survival
<sup><xref ref-type="bibr" rid="ref-36">36</xref>,
<xref ref-type="bibr" rid="ref-37">37</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CHD7</td>
<td align="left" colspan="1" rowspan="1" valign="top">Member of the chromo
<break></break>helicase domain family</td>
<td align="left" colspan="1" rowspan="1" valign="top">CHD7 is required for oligodendrocyte differentiation
<break></break>and remyelination in the spinal cord
<sup><xref ref-type="bibr" rid="ref-6">6</xref>,
<xref ref-type="bibr" rid="ref-38">38</xref>,
<xref ref-type="bibr" rid="ref-39">39</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CHD8</td>
<td align="left" colspan="1" rowspan="1" valign="top">Member of the chromo
<break></break>helicase domain family</td>
<td align="left" colspan="1" rowspan="1" valign="top">CHD8 has been linked to autism disorder with
<break></break>white matter defects. CHD8 knockout in the
<break></break>oligodendrocyte lineage leads to myelination
<break></break>defects
<sup><xref ref-type="bibr" rid="ref-40">40</xref>,
<xref ref-type="bibr" rid="ref-41">41</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="10" valign="top">
<bold>Histone acetylation</bold>
<break></break>
<bold>modifiers</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">EP300 (also known as p300)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Histone acetyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top">Associated with Rubinstein–Taybi syndrome
<sup><xref ref-type="bibr" rid="ref-42">42</xref>,
<xref ref-type="bibr" rid="ref-43">43</xref></sup> and
<break></break>regulates oligodendrocyte differentiation
<sup><xref ref-type="bibr" rid="ref-44">44</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">EP400 (E1A Binding Protein
<break></break>P400)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Key subunit of TIP60
<break></break>histone acetyltransferase
<break></break>complex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Deletion in CNP
<sup>+</sup> oligodendrocytes leads to defects
<break></break>in terminal differentiation and hypomyelination
<sup><xref ref-type="bibr" rid="ref-45">45</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">HDAC1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Class I histone
<break></break>deacetylase (HDAC)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates oligodendrocyte differentiation via
<break></break>co-repressor complexes
<sup><xref ref-type="bibr" rid="ref-46">46</xref>,
<xref ref-type="bibr" rid="ref-47">47</xref>,
<xref ref-type="bibr" rid="ref-48">48</xref></sup> and has non–
<break></break>histone-dependent effects in oligodendrocyte
<break></break>differentiation
<sup><xref ref-type="bibr" rid="ref-49">49</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">HDAC2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Class I HDAC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Functionally redundant regulation of
<break></break>oligodendrocyte differentiation with HDAC1
<sup><xref ref-type="bibr" rid="ref-46">46</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">HDAC3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Class I HDAC
<break></break>Complexes with co-
<break></break>repressors NCOR/SMRT</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates the fate choice of primitive OPCs
<break></break>between astrocytic and oligodendrocytic fates and
<break></break>myelination
<sup><xref ref-type="bibr" rid="ref-44">44</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SIRT1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Class III NAD
<sup>+</sup> HDAC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stage-dependent effects on OPC proliferation.
<break></break>Increased OPC differentiation when knocked out in
<break></break>OPCs
<sup><xref ref-type="bibr" rid="ref-50">50</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SIRT2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Class III NAD
<sub>+</sub> HDAC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Highly expressed in mature oligodendrocytes. Its
<break></break>level is positively correlated with oligodendrocyte
<break></break>differentiation
<sup><xref ref-type="bibr" rid="ref-51">51</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">HDAC6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Class II HDAC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates oligodendrocyte differentiation via is
<break></break>acetylation of tubulin in the cytoskeleton
<sup><xref ref-type="bibr" rid="ref-52">52</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">HDAC10</td>
<td align="left" colspan="1" rowspan="1" valign="top">Class II HDAC</td>
<td align="left" colspan="1" rowspan="1" valign="top">No clear role, likely due to functional redundancy
<break></break>with other HDACs in its regulation of OLIG1 nuclear
<break></break>localization
<sup><xref ref-type="bibr" rid="ref-49">49</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">HDAC11</td>
<td align="left" colspan="1" rowspan="1" valign="top">Class IV HDAC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates oligodendrocyte differentiation possibly
<break></break>via modulating regulatory elements of myelin-
<break></break>related genes
<sup><xref ref-type="bibr" rid="ref-53">53</xref>,
<xref ref-type="bibr" rid="ref-54">54</xref>,
<xref ref-type="bibr" rid="ref-55">55</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4" valign="top">
<bold>Histone methyl-</bold>
<break></break>
<bold>transferases</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">COMPASS-like complex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Major subunits include
<break></break>SETD1A, MLL1, and MLL2
<break></break>(KMT2A)</td>
<td align="left" colspan="1" rowspan="1" valign="top">MLL2 works with CHD8 to deposit H3K4me3
<break></break>at active promotors of oligodendrocyte lineage
<break></break>genes
<sup><xref ref-type="bibr" rid="ref-41">41</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">PRC2 complexes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Major subunits include
<break></break>EZH2, EED, and SUZ12</td>
<td align="left" colspan="1" rowspan="1" valign="top">Responsible for H3K27me3 deposition. Promotes
<break></break>oligodendrogenesis and OPC differentiation
<sup><xref ref-type="bibr" rid="ref-56">56</xref>,
<xref ref-type="bibr" rid="ref-57">57</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">PRMT1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Catalyzes histone arginine
<break></break>methylation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Required for proper OPC differentiation resulting in
<break></break>hypomyelination defects
<sup><xref ref-type="bibr" rid="ref-58">58</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">PRMT5</td>
<td align="left" colspan="1" rowspan="1" valign="top">Catalyzes histone arginine
<break></break>methylation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Required for proper OPC differentiation resulting in
<break></break>hypomyelination defects
<sup><xref ref-type="bibr" rid="ref-59">59</xref>–
<xref ref-type="bibr" rid="ref-61">61</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3" valign="top">
<bold>DNA methyl-</bold>
<break></break>
<bold>transferases and</bold>
<break></break>
<bold>demethylases</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">DNMT1</td>
<td align="left" colspan="1" rowspan="1" valign="top">DNA methyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top">Knockout early development impairs OPC
<break></break>differentiation and results in hypomyelination
<sup><xref ref-type="bibr" rid="ref-62">62</xref></sup>. Has
<break></break>no effect on myelin repair
<sup><xref ref-type="bibr" rid="ref-55">55</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">DNMT3a</td>
<td align="left" colspan="1" rowspan="1" valign="top">DNA methyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top">Plays a role in myelin repair after injury but not early
<break></break>development of the oligodendrocyte lineage
<sup><xref ref-type="bibr" rid="ref-55">55</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TET1–3
<break></break>(ten-eleven translocation)</td>
<td align="left" colspan="1" rowspan="1" valign="top">DNA demethylases that
<break></break>catalyze the conversion of
<break></break>5mC to 5hmC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Differentially regulated at different stages during OL
<break></break>development. Tet1 is required for OL differentiation
<break></break>
<italic>in vitro</italic>
<sup><xref ref-type="bibr" rid="ref-63">63</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="5" valign="top">
<bold>microRNAs</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dicer</td>
<td align="left" colspan="1" rowspan="1" valign="top">Enzyme responsible for
<break></break>processing microRNAs
<break></break>into mature form</td>
<td align="left" colspan="1" rowspan="1" valign="top">Required for OPC differentiation, myelination, and
<break></break>myelin maintenance
<sup><xref ref-type="bibr" rid="ref-64">64</xref>–
<xref ref-type="bibr" rid="ref-66">66</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>miR-219</italic>
</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-219 is necessary and sufficient to induce
<break></break>differentiation
<sup><xref ref-type="bibr" rid="ref-65">65</xref>,
<xref ref-type="bibr" rid="ref-66">66</xref></sup>. Also required for remyelination
<break></break>after lysophosphatidylcholine (LPC)-induced
<break></break>demyelination
<sup><xref ref-type="bibr" rid="ref-67">67</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>miR-338</italic>
</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-338 is dispensable for OPC differentiation
<break></break>or myelination
<italic>in vivo</italic> but has synergistic with
<break></break>miR-219
<sup><xref ref-type="bibr" rid="ref-67">67</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>miR-212</italic>
</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Negatively regulates common oligodendrocyte and
<break></break>myelin-related genes by miR-212
<sup><xref ref-type="bibr" rid="ref-68">68</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>miR-125a-3p</italic>
</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Upregulated in cerebrospinal fluid from multiple
<break></break>sclerosis patients with active demyelinating
<break></break>lesions. Negatively regulates oligodendrocyte
<break></break>differentiation
<sup><xref ref-type="bibr" rid="ref-69">69</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="6" valign="top">
<bold>Long non-coding</bold>
<break></break>
<bold>RNAs</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>lncOL1</italic>
</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">LncOL1 positively regulates OPC differentiation
<break></break>while having no effect on OPC formation. Affects
<break></break>timing of myelinogenesis but not the maintenance
<break></break>of myelin
<sup><xref ref-type="bibr" rid="ref-56">56</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Lnc-OPC</italic>
</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Knockdown of lnc-OPC in NPCs limited their
<break></break>differentiation into OPCs without affecting NPC
<break></break>proliferation
<sup><xref ref-type="bibr" rid="ref-70">70</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Pcdh17it</italic>
</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">A marker of the immature premyelinating
<break></break>oligodendrocyte population
<sup><xref ref-type="bibr" rid="ref-71">71</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SOX8OT</italic>
</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates oligodendrocyte differentiation through
<break></break>targeting SOX8
<sup><xref ref-type="bibr" rid="ref-72">72</xref>,
<xref ref-type="bibr" rid="ref-73">73</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Neat1</italic>
</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Knockout reduces the number of oligodendrocytes
<break></break>in the frontal cortex
<sup><xref ref-type="bibr" rid="ref-74">74</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Lnc158</italic>
</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Correlates with oligodendrocyte differentiation-
<break></break>associated gene expression
<sup><xref ref-type="bibr" rid="ref-75">75</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3" valign="top">
<italic>N</italic>
<bold><sup>6</sup>-methyl-adenosine</bold>
<break></break>
<bold>(m
<sup>6</sup>A) modifiers</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">METTL14</td>
<td align="left" colspan="1" rowspan="1" valign="top">m6A RNA writer</td>
<td align="left" colspan="1" rowspan="1" valign="top">Required for OPC differentiation and proper
<break></break>myelination
<sup><xref ref-type="bibr" rid="ref-76">76</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">PRRC2A</td>
<td align="left" colspan="1" rowspan="1" valign="top">An m6A RNA binding
<break></break>protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">Highly expressed in OPCs and white matter
<break></break>tracks. Required for normal OPC proliferation and
<break></break>differentiation
<sup><xref ref-type="bibr" rid="ref-77">77</xref></sup>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">FTO</td>
<td align="left" colspan="1" rowspan="1" valign="top">m6A RNA demethylase
<break></break>(alpha-ketoglutarate–
<break></break>dependent dioxygenase)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Knockout mimics the effects of PRRC2A
<break></break>overexpression increasing Olig2 expression
<sup><xref ref-type="bibr" rid="ref-77">77</xref></sup>.</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>CHD, chromodomain helicase DNA-binding; HDAC, histone deacetylase; OL, oligodendrocyte cell line; OPC, oligodendrocyte progenitor cell; NPC, neural progenitor cell.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>ATP-dependent chromatin remodelers in oligodendrocyte lineage progression and regeneration</title>
<p>ATP-dependent chromatin remodeling uses ATP to remodel the nucleosome, opening up areas for enhancing transcription, and is critical for neural cell growth and differentiation
<sup><xref ref-type="bibr" rid="ref-79">79</xref>,
<xref ref-type="bibr" rid="ref-80">80</xref></sup>. Early work in cell cultures showed that OPCs differentiating into mature oligodendrocytes underwent substantial chromatin reorganization within the nucleus
<sup><xref ref-type="bibr" rid="ref-81">81</xref></sup>. The chromatin remodelers consist of several multi-subunit complexes which fall into four major families: the SWI/SNF family with the major ATPase subunits Brahma-related 1 (BRG1, also known as Smarca4) and Brahma (BRM, also known as SMARCA2), the INO80 family which includes the ATPases INO80 and SRCAP, the ISWI family with ATPase subunits SNF2L and SNF2H, and the chromodomain helicase DNA-binding (CHD) family consisting of CHD1–9
<sup><xref ref-type="bibr" rid="ref-80">80</xref>,
<xref ref-type="bibr" rid="ref-82">82</xref>,
<xref ref-type="bibr" rid="ref-83">83</xref></sup>. Of these, the SWI/SNF family and the CHD family members are dynamically regulated over the course of OPC specification and differentiation and have been implicated in oligodendrocyte development and myelination (
<xref ref-type="fig" rid="f2">Figure 2</xref>).</p>
<fig fig-type="figure" id="f2" orientation="portrait" position="anchor">
<label>Figure 2. </label>
<caption>
<title>Global expression levels of key epigenetic regulators during oligodendrocyte differentiation from progenitor cells.</title>
<p>Epigenetic modifiers, including ATP-dependent chromatin remodelers, histone acetyltransferases and deacetylases, histone methyltransferases, and demethylases, are critical components of the differentiation process, according to the data from a bulk RNA sequencing dataset
<sup><xref ref-type="bibr" rid="ref-92">92</xref></sup>. The change of epigenetic modifiers across oligodendrocyte differentiation is depicted. The global changes of expression levels in the epigenetic modifications themselves are based on the studies
<sup><xref ref-type="bibr" rid="ref-41">41</xref>,
<xref ref-type="bibr" rid="ref-44">44</xref>,
<xref ref-type="bibr" rid="ref-62">62</xref>,
<xref ref-type="bibr" rid="ref-63">63</xref>,
<xref ref-type="bibr" rid="ref-66">66</xref>,
<xref ref-type="bibr" rid="ref-93">93</xref></sup>. OPC, oligodendrocyte progenitor cell.</p>
</caption>
<graphic xlink:href="f1000research-9-23002-g0001"></graphic>
</fig>
<sec>
<title>SWI/SNF family members</title>
<p>The SWI/SNF family of ATPase dependent chromatin remodelers have been shown to play critical roles in the development of the oligodendrocyte lineage. Deletion of
<italic>Brg1/Smarca4</italic>, the core helicase component of the SWI/SNF family, in NPCs inhibits oligodendrocyte and astrocyte lineage development while increasing neuronal differentiation in the ventricular zone of the developing brain
<sup><xref ref-type="bibr" rid="ref-80">80</xref>,
<xref ref-type="bibr" rid="ref-84">84</xref></sup>. A lineage-specific transcription factor, OLIG2, can recruit the BRG1/SWI/SNF complex to the promoters and enhancers of oligodendrocyte lineage genes such as
<italic>Sox10</italic> to activate their transcription. BRG1 is also necessary for OPC differentiation. BRG1 expression increases after induction of rat OPC differentiation with T3 thyroid hormone
<sup><xref ref-type="bibr" rid="ref-36">36</xref></sup>. These increasing levels are critical for OPC differentiation as conditional knockout in
<italic>Olig1</italic>-expressing oligodendrocyte progenitors and PDGFRa-expressing OPCs
<italic>in vivo</italic> leads to oligodendrocyte differentiation defects and profound dysmyelination defects
<sup><xref ref-type="bibr" rid="ref-36">36</xref></sup> (JW and QL, unpublished). Of note, the loss of
<italic>Brg1</italic> does not affect OPC survival in culture or
<italic>in vivo</italic>
<sup><xref ref-type="bibr" rid="ref-36">36</xref></sup>. However,
<italic>Brg1</italic> knockout in later OPCs, such as NG2
<sup>+</sup> or CNP
<sup>+</sup>, committed or post-mitotic OPCs, respectively, had progressively less severe effects on differentiation
<sup><xref ref-type="bibr" rid="ref-37">37</xref></sup>, suggesting that BRG1 effects are stage-dependent. This stage-dependent severity suggests that BRG1 activates early pro-differentiation factors, such as SOX10, that can continue to mediate downstream genetic programs in oligodendrocyte lineage progression despite the upstream loss of BRG1
<sup><xref ref-type="bibr" rid="ref-36">36</xref>,
<xref ref-type="bibr" rid="ref-37">37</xref></sup>. In addition, other chromatin remodelers such as CHD8 or CHD7 (discussed below) potentially compensate for the loss of BRG1 at later stages.</p>
</sec>
<sec>
<title>CHD family members</title>
<p>CHD7 is highly enriched in the oligodendrocyte lineage, especially in differentiating oligodendrocytes.
<italic>CHD7</italic> mutations result in a series of birth defects called CHARGE syndrome, which exhibits impaired white matter development and myelination in addition to other congenital developmental abnormalities
<sup><xref ref-type="bibr" rid="ref-85">85</xref>,
<xref ref-type="bibr" rid="ref-86">86</xref></sup>. CHD7, like BRG1 above, does not affect OPC formation but instead causes defects in OPC differentiation
<sup><xref ref-type="bibr" rid="ref-6">6</xref>,
<xref ref-type="bibr" rid="ref-38">38</xref>,
<xref ref-type="bibr" rid="ref-39">39</xref></sup>. In fact,
<italic>Chd7</italic> is a direct target of the OLIG2/BRG1 complex and its expression is greatly increased by the binding of this complex at its promoter
<sup><xref ref-type="bibr" rid="ref-6">6</xref></sup>. CHD7 can complex with SOX10 to activate downstream regulators of oligodendrocyte differentiation. CHD7 activates the expression of OPC pro-differentiation regulators, including SOX10 and NKX2-2
<sup><xref ref-type="bibr" rid="ref-39">39</xref></sup>, as well as other oligodendrocyte-expressing transcription factors such as Osterix/Sp7 and Creb3l2
<sup><xref ref-type="bibr" rid="ref-6">6</xref>,
<xref ref-type="bibr" rid="ref-39">39</xref></sup>. Intriguingly, deletion of Chd7 in PDGFRa
<sup>+</sup> OPCs appears to impair OPC survival via p53 upregulation
<sup><xref ref-type="bibr" rid="ref-39">39</xref></sup>. CHD7 binds to the
<italic>p53</italic> promotor in OPCs and limits p53 expression to maintain the survival of OPCs
<sup><xref ref-type="bibr" rid="ref-39">39</xref></sup>.</p>
<p>CHD7 is also required for remyelination after lysolecithin-induced demyelination
<sup><xref ref-type="bibr" rid="ref-6">6</xref></sup> or spinal cord laminectomy, wherein it interacts with SOX2 to drive OPC differentiation
<sup><xref ref-type="bibr" rid="ref-38">38</xref></sup>.
<italic>Chd7</italic> deletion impairs OPC proliferation after spinal cord injury
<sup><xref ref-type="bibr" rid="ref-38">38</xref></sup> but not in the developing brain
<sup><xref ref-type="bibr" rid="ref-6">6</xref>,
<xref ref-type="bibr" rid="ref-39">39</xref></sup>, suggesting a context-dependent CHD7 regulation of OPC proliferation. However, CHD7 appears to be dispensable for the maturation of oligodendrocytes, possibly due to compensation by other CHD members such as CHD8
<sup><xref ref-type="bibr" rid="ref-39">39</xref></sup>, which has been shown to work together with CHD7 to regulate OPC survival and maturation
<sup><xref ref-type="bibr" rid="ref-39">39</xref></sup>.</p>
<p>Another CHD family member, CHD8, is also critical for proper oligodendrocyte development. CHD8 has been linked to a subset of autism disorders, which exhibit a defect in white matter tracts and myelination
<sup><xref ref-type="bibr" rid="ref-40">40</xref>,
<xref ref-type="bibr" rid="ref-41">41</xref>,
<xref ref-type="bibr" rid="ref-87">87</xref>–
<xref ref-type="bibr" rid="ref-89">89</xref></sup>.
<italic>Chd8</italic> knockout in
<italic>Olig1</italic>
<sup>+</sup> progenitors causes defects in CNS myelination, particularly in the spinal cord because of severe reductions in PDGFRα-expressing OPCs in this region
<sup><xref ref-type="bibr" rid="ref-41">41</xref></sup>, suggesting a region-specific role of CHD8 in OPC survival and differentiation. Deletion of
<italic>Chd8</italic> at the post-natal stages with an inducible PDGFRα-CreER driver also blocks OPC differentiation. The defects in oligodendrocyte differentiation are due to the cell-specific loss of
<italic>Chd8</italic> in the oligodendrocyte lineage as there are no defects seen after
<italic>Chd8</italic> knockout in post-mitotic neurons
<sup><xref ref-type="bibr" rid="ref-41">41</xref></sup>. This suggests that the myelination defects seen in
<italic>CHD8</italic> mutant patients are cell-autonomous defects due to the loss of
<italic>CHD8</italic>. Remyelination after lysophosphatidylcholine (LPC)-induced demyelinating lesions in the spinal cord is also dependent on CHD8 expression
<sup><xref ref-type="bibr" rid="ref-41">41</xref></sup>. CHD8 dysregulation may be an important factor for white matter pathogenesis and remyelination failure given the critical role of CHD8 for OPC replenishment and remyelination in demyelinating lesions.</p>
<p>CHD7 and CHD8 have similar structures and can bind many of the same targets. However, they target different gene regions during oligodendrocyte differentiation. CHD7 predominantly binds to promotor regions in OPCs but switches to enhancer regions in oligodendrocytes
<sup><xref ref-type="bibr" rid="ref-39">39</xref></sup>. CHD8, in contrast, binds predominantly to promotor elements near transcription start sites marked by an activating histone mark H3K4me3 in OPCs and oligodendrocytes where it recruits an H3K4 activating histone methyltransferase MLL2 (mixed lineage leukemia 2) complex to drive expression of oligodendrocyte lineage genes
<sup><xref ref-type="bibr" rid="ref-41">41</xref></sup>. MLL2–4 and other family members can form a macromolecular complex called COMPASS (complex of proteins associated with Set1) to methylate H3K4 and regulate gene transcription
<sup><xref ref-type="bibr" rid="ref-90">90</xref></sup>. Strikingly, blocking lysine demethylase KDM5, an enzyme that erases methylation on H3K4
<sup><xref ref-type="bibr" rid="ref-91">91</xref></sup>, with a pan-KDM5 inhibitor CPI-455 rescues the differentiation defects in
<italic>Chd8</italic> mutant OPCs
<sup><xref ref-type="bibr" rid="ref-41">41</xref></sup>, suggesting that targeting this eraser to enhance H3K4me3 levels might facilitate the restoration of myelination defects caused by CHD8 defects.</p>
<p>The chromatin remodelers may all work together to regulate oligodendrocyte development but each has its own preferences for regulatory elements and mechanisms to control expression of specific sets of targeted genes. Of these, CHD8 appears to turn on the earliest, eventually promoting BRG1 expression which in turn induces CHD7 expression
<sup><xref ref-type="bibr" rid="ref-6">6</xref></sup>. This successive signaling cascade enables the progression from OPCs to mature myelinating oligodendrocytes and likely forms convergent points upon which other checkpoints and regulatory mechanisms act to facilitate this development. Nonetheless, these chromatin remodelers could operate simultaneously in a non-linear fashion to promote oligodendrocyte lineage progression.</p>
</sec>
</sec>
<sec>
<title>Histone acetylation control of cell fates and differentiation in the oligodendrocyte lineage</title>
<p>Histone acetylation, in particular, has been strongly implicated in the regulation of oligodendrocyte development. The addition and elimination of acetyl groups are balanced through the competing work of histone acetyltransferases (HATs)
<sup><xref ref-type="bibr" rid="ref-94">94</xref></sup> and histone deacetylases (HDACs).</p>
<sec>
<title>HATs</title>
<p>The activity of HATs is responsible for the acetylation of histones, leading to relaxed chromatin coiling and increased gene expression. The acetylation of histone H3 on lysine 27 (H3K27ac) is often deposited at active regulatory elements such as enhancers and promoters and is positively correlated with the activation of gene transcription
<sup><xref ref-type="bibr" rid="ref-95">95</xref></sup>. H3K27 acetylation is catalyzed by multiple HATs, including p300 (also known as EP300), CREB-binding protein (CBP), TIP60, and PCAF
<sup><xref ref-type="bibr" rid="ref-96">96</xref>,
<xref ref-type="bibr" rid="ref-97">97</xref></sup>. Histone acetylation status can be further recognized by bromo-, PHD-, Tudor-, or WD40-domain-containing transcription activating regulators, which further modulate target gene expression
<sup><xref ref-type="bibr" rid="ref-95">95</xref>,
<xref ref-type="bibr" rid="ref-98">98</xref>–
<xref ref-type="bibr" rid="ref-100">100</xref></sup>.</p>
<p>In line with a critical role for histone acetylation in regulating the oligodendrocyte lineage, the loss of multiple HATs can lead to defects in the myelination process. Deletion of EP400, a key subunit of the TIP60 HAT complex, in
<italic>Cnp</italic>-expressing oligodendroglial cells results in a defect in oligodendrocyte terminal differentiation, leading to profound hypomyelination
<sup><xref ref-type="bibr" rid="ref-45">45</xref></sup>. A genetic disorder, Rubinstein–Taybi syndrome, is associated with mutations in p300 (also known as EP300), which is characterized in part by hypoplasia of the corpus collosum and congenital hypomyelination
<sup><xref ref-type="bibr" rid="ref-42">42</xref>,
<xref ref-type="bibr" rid="ref-43">43</xref></sup>. The role of p300 in controlling oligodendrocyte development is still being explored, but p300 has been shown to interact with HDAC3 (discussed in more detail below) partly facilitating the role of HDAC3 in promoting oligodendrocyte as opposed to astrocytic cell lineages during early differentiation from NPCs via its promotion of
<italic>Olig2</italic> expression
<sup><xref ref-type="bibr" rid="ref-101">101</xref></sup>. Also, inhibition of p300 activity itself can lead to pronounced defects in OPC differentiation (JW and QL, unpublished).</p>
</sec>
<sec>
<title>HDACs</title>
<p>Histone acetylation status can be reversed by HDACs. Mammals possess four classes of HDACs. Class I contains HDACs 1–3 and 8, class II contains HDACs 4–7 and 9 and 10, class III are NAD-dependent HDACs (also known as sirtuins, encompassing SIRT1–7), and finally class IV contains one HDAC, HDAC11
<sup><xref ref-type="bibr" rid="ref-102">102</xref>,
<xref ref-type="bibr" rid="ref-103">103</xref></sup>. Pharmacological studies using HDAC inhibitors have indicated the importance of HDACs in oligodendrocyte fate specification and differentiation. Treating rat NPCs with valproic acid inhibited oligodendrogenesis and astrogenesis while promoting neurogenesis likely through NeuroD1 upregulation following the inhibition of HDAC activity
<sup><xref ref-type="bibr" rid="ref-104">104</xref></sup>. Blocking HDAC activity with pan inhibitors also disrupts the differentiation of OPCs into mature oligodendrocytes
<sup><xref ref-type="bibr" rid="ref-105">105</xref></sup>. The timing of this treatment appears to be critical. Treating cells with pan-HDAC inhibitors after the differentiation process has been shown to have minimal effect on oligodendrocyte differentiation
<sup><xref ref-type="bibr" rid="ref-106">106</xref></sup>. These studies indicate that HDACs play various roles at different stages during OPC differentiation and subsequent myelination. However, classic pan-HDAC inhibitors are non-specific and target HDACs across multiple classes. Genetic manipulation can specifically target individual HDACs to define their specific functions during oligodendrocyte lineage progression.</p>
</sec>
<sec>
<title>Class I HDACs</title>
<p>The expression levels and functions of class I HDACs are important for oligodendrocyte fate specification and differentiation (
<xref ref-type="fig" rid="f2">Figure 2</xref>). HDAC1 and HDAC2, when knocked out individually in the oligodendrocyte lineage, have no obvious effects on OPC formation, proliferation, or differentiation
<sup><xref ref-type="bibr" rid="ref-46">46</xref></sup>. However, the double-knockout animals die shortly after birth, and analysis revealed a severe defect in OPC proliferation or differentiation in these animals, suggesting that HDAC1 and HDAC2 can functionally compensate for the loss of the other in oligodendrocyte lineage determination
<sup><xref ref-type="bibr" rid="ref-46">46</xref></sup>. Another HDAC class I family member, HDAC3, has been implicated in the control of oligodendrocyte lineage specification
<sup><xref ref-type="bibr" rid="ref-44">44</xref></sup> but differs from those effects observed in HDAC1. HDAC3 deletion at the same stages as HDAC1 and 2 above results in a switch from oligodendrocyte to astrocytic fates, suggesting that HDAC3 regulates the fate choice of primitive OPCs between astrocytic and oligodendrocytic cell lineages
<sup><xref ref-type="bibr" rid="ref-44">44</xref></sup>.</p>
<p>HDACs have been shown to exhibit non–histone dependent functions during oligodendrocyte development. HDAC1/2 co-repressor complexes can compete with β-catenin for binding to TCF7L2 (TCF4), a member of the TCF transcription factor family, resulting in the disinhibition of TCF7L2, which then is free to promote OPC differentiation
<sup><xref ref-type="bibr" rid="ref-46">46</xref>,
<xref ref-type="bibr" rid="ref-47">47</xref>,
<xref ref-type="bibr" rid="ref-48">48</xref></sup>. This is an example of how non-enzymatic activity of HDACs through protein–protein interaction in addition to the deacetylase activity can function to regulate genetic expression. HDAC1 can also be recruited by YY1 transcription factor to the promotor of oligodendrocyte differentiation inhibitory genes such as
<italic>Id4</italic> to reduce their expression
<sup><xref ref-type="bibr" rid="ref-107">107</xref>,
<xref ref-type="bibr" rid="ref-108">108</xref></sup>. In addition, HDAC1 and HDAC3 can deacetylate the OLIG1 transcription factor, increasing its likelihood of nuclear translocation and ultimate promotion of OPC differentiation
<sup><xref ref-type="bibr" rid="ref-49">49</xref></sup>.</p>
<p>HDAC activity can be modulated through co-regulators or covalent modifications
<sup><xref ref-type="bibr" rid="ref-109">109</xref></sup>. For example, casein kinase 2 (CK2) phosphorylates HDAC3 to activate its activity while phosphatase 4 dephosphorylates it
<sup><xref ref-type="bibr" rid="ref-110">110</xref></sup>. Of interest,
<italic>in vitro</italic> experiments revealed that the CK2 kinase, which activates HDAC3, also elevates expression of OLIG2, a critical transcription factor for initiating oligodendroglial cell fate
<sup><xref ref-type="bibr" rid="ref-111">111</xref></sup>. HDAC3 also forms protein complexes with co-repressor complexes such as NCOR and SMRT to regulate its activity
<sup><xref ref-type="bibr" rid="ref-112">112</xref></sup>. NCOR has been shown to negatively regulate astrogenesis through inhibiting JAK-STAT signaling, activation of which leads to astrocyte differentiation
<sup><xref ref-type="bibr" rid="ref-113">113</xref></sup>. In addition, HDAC3/NCOR can deacetylate and inactivate astrocyte-promoting factor STAT3 and therefore promote oligodendrogenesis while inhibiting the astroglial fate
<sup><xref ref-type="bibr" rid="ref-44">44</xref></sup>. HDAC3 also forms complexes with the HAT p300, to regulate OLIG2 expression levels during OPC specification
<sup><xref ref-type="bibr" rid="ref-44">44</xref></sup>. This interaction likely indicates that the coordinated activity of two opposing factors is required for oligodendrocyte and astrocytic lineage fate decisions.</p>
<p>HDAC3 functions not only as a transcriptional co-repressor, as one may assume from its histone deacetylation activity, but also as a transcriptional co-activator as in its role in the activation of retinoic acid response elements
<sup><xref ref-type="bibr" rid="ref-114">114</xref>,
<xref ref-type="bibr" rid="ref-115">115</xref></sup>. It is worth noting that HDAC3 deacetylase activity may not be vital for oligodendrocyte development. HDAC3 requires NCOR and SMRT to promote its deacetylation activity. Deleting the deacetylase-activating domains (DADs) in NCOR and SMRT abrogates the deacetylase activity of HDAC3. However, the DAD deletion mice survive to adulthood and exhibit normal myelination whereas the ablation of HDAC3 is embryonic lethal
<sup><xref ref-type="bibr" rid="ref-116">116</xref></sup>. Although the function of HDAC3 catalytic site mutants remains to be determined, the current data suggest that HDAC3 may serve as a scaffold for multi-component transcriptional regulatory complexes vital for oligodendrocyte myelination.</p>
</sec>
<sec>
<title>Other HDAC classes</title>
<p>Among class II HDACs, HDAC6 has been shown in rat oligodendrocyte cultures to acetylate the microtubule-associated protein tau and α-tubulin, both of which are required for normal oligodendrocyte development
<sup><xref ref-type="bibr" rid="ref-52">52</xref></sup>. HDAC10, along with HDAC1 and HDAC3, has also been shown to regulate the nuclear localization of OLIG1 for oligodendrocyte maturation
<sup><xref ref-type="bibr" rid="ref-49">49</xref></sup>. It is worth noting that the enzymatic activity of class II HDACs is dependent on the HDAC3/SMRT/N-CoR complex
<sup><xref ref-type="bibr" rid="ref-117">117</xref></sup>.</p>
<p>The class III HDACs SIRT1 and SIRT2 have been shown to regulate early oligodendrocyte lineage determination
<sup><xref ref-type="bibr" rid="ref-50">50</xref>,
<xref ref-type="bibr" rid="ref-51">51</xref>,
<xref ref-type="bibr" rid="ref-118">118</xref></sup>. SIRT2, in particular, is highly expressed in mature oligodendrocytes
<sup><xref ref-type="bibr" rid="ref-119">119</xref></sup> and regulates the differentiation of oligodendrocytes as blocking its activity or overexpressing it prevents or promotes differentiation of CG4 oligodendroglial cells, respectively
<sup><xref ref-type="bibr" rid="ref-120">120</xref>–
<xref ref-type="bibr" rid="ref-122">122</xref></sup>. This class of HDACs also relies on NAD as a co-factor for deacetylase activity
<sup><xref ref-type="bibr" rid="ref-123">123</xref></sup>. The loss of NAMPT, the rate-limiting enzyme for NAD biosynthesis in mammals, leads to defective oligodendrocyte development
<sup><xref ref-type="bibr" rid="ref-118">118</xref>,
<xref ref-type="bibr" rid="ref-124">124</xref></sup>. Like those of many other epigenetic factors, the effects that SIRT1 and SIRT2 have on development are stage-dependent. For example,
<italic>Sirt1</italic> knockout in NPCs increases OPC proliferation
<sup><xref ref-type="bibr" rid="ref-50">50</xref></sup> while
<italic>Sirt1</italic> knockout in PDGFRa
<sup>+</sup> OPCs promotes cell cycle exit and OPC differentiation
<sup><xref ref-type="bibr" rid="ref-125">125</xref></sup>. Notably, SIRT2 is depleted in myelin sheathes of PLP-deficient oligodendrocytes, a model for spastic paraplegia, suggesting that SIRT2 might have a role in myelin sheath maintenance and provide trophic support of axons
<sup><xref ref-type="bibr" rid="ref-126">126</xref></sup>.</p>
<p>Finally, the class IV HDAC, HDAC11 has been shown to regulate H3K9 and H3K14 acetylation and expression levels of
<italic>Mbp</italic> and
<italic>Plp</italic> genes
<sup><xref ref-type="bibr" rid="ref-53">53</xref>,
<xref ref-type="bibr" rid="ref-54">54</xref></sup>. HDAC11 overexpression enhances the maturation of an oligodendrocyte cell line (OL-1)
<italic>in vitro</italic>
<sup><xref ref-type="bibr" rid="ref-53">53</xref>,
<xref ref-type="bibr" rid="ref-54">54</xref></sup>, suggesting a potential role of HDAC11 in regulating myelin gene expression. At present, how the function of each HAT and HDAC is controlled, individually and coordinately, on a system-wide level to regulate the complex processes of oligodendrocyte development and myelination remains to be defined. This is of particular importance given the reiterative involvement of many HAT and HDAC enzymes in the gene regulatory network during CNS development and regeneration.</p>
</sec>
</sec>
<sec>
<title>Histone methylation regulates oligodendrocyte differentiation</title>
<p>Histone methylation can be linked to either gene activation or gene repression. The activating histone mark H3K4 trimethylation (H3K4me3) is deposited mainly at promoter elements and associated with gene transcription
<sup><xref ref-type="bibr" rid="ref-127">127</xref></sup>. The COMPASS-like complex, consisting of SETD1A and MLL1/2, is a major enzyme responsible for H3K4me3 deposition
<sup><xref ref-type="bibr" rid="ref-128">128</xref>,
<xref ref-type="bibr" rid="ref-129">129</xref></sup>, although its function in oligodendrocyte development has not been fully defined.</p>
<p>During differentiation from a more plastic state to a more differentiated state, the level of repressive histone marks, for example, H3K27me3 and H3K9me3 increases across many different cell types
<sup><xref ref-type="bibr" rid="ref-130">130</xref>,
<xref ref-type="bibr" rid="ref-131">131</xref></sup>, including oligodendrocyte lineage cells
<sup><xref ref-type="bibr" rid="ref-56">56</xref>,
<xref ref-type="bibr" rid="ref-93">93</xref></sup>. The histone methyltransferases mediating the deposition of these marks are critical in the differentiation of oligodendrocytes. Inhibition of H3K9 histone methyltransferases in cell culture via pharmacological inhibitors or shRNAs suggested a role of H3K9 deposition in the progression of the OL lineage and the suppression of neuronal gene programs
<sup><xref ref-type="bibr" rid="ref-93">93</xref></sup>. However, the
<italic>in vivo</italic> role of these H3K9 histone methyltransferases in oligodendrocyte development remains to be defined.</p>
<p>The importance of H3K27 trimethylation (H3K27me3) in oligodendrocyte development is more defined. Polycomb repressive complex 2 (PRC2), consisting of EZH2, EED, and SUZ12, is the sole enzyme responsible for H3K27me3 in mammals
<sup><xref ref-type="bibr" rid="ref-132">132</xref>–
<xref ref-type="bibr" rid="ref-134">134</xref></sup>. Expression of PRC2 complex components exhibits a spatiotemporal-specific pattern
<sup><xref ref-type="bibr" rid="ref-135">135</xref>–
<xref ref-type="bibr" rid="ref-137">137</xref></sup>, suggesting that individual PRC2 subunits may play distinct functions during oligodendrocyte development and myelination. EZH2, the core catalytic subunit of PRC2 mediating its methyltransferase activity, promotes oligodendrogenesis from neural stem cells as opposed to astrocyte formation in a dose-dependent manner
<sup><xref ref-type="bibr" rid="ref-57">57</xref></sup>. In addition, the loss of
<italic>Ezh2</italic> at later stages in
<italic>Olig1</italic>-expressing progenitors prevents OPC differentiation, decreasing the number of mature oligodendrocytes
<italic>in vivo</italic>
<sup><xref ref-type="bibr" rid="ref-56">56</xref></sup>. These observations suggest that elevation of H3K27me3 levels is required for oligodendrocyte differentiation. Of note, mutations in the histone such as H3.3K27M precludes PRC2-mediated H3K27me3
<sup><xref ref-type="bibr" rid="ref-138">138</xref>,
<xref ref-type="bibr" rid="ref-139">139</xref></sup>. This mutation limits the capacity for OPC differentiation and is a major factor contributing to the development of malignant diffuse intrinsic pontine glioma (DIPG)
<sup><xref ref-type="bibr" rid="ref-138">138</xref>,
<xref ref-type="bibr" rid="ref-140">140</xref>,
<xref ref-type="bibr" rid="ref-141">141</xref></sup>. OPCs or pri-OPCs have been implicated as the tumor cells of origin for H3K27M midline gliomas
<sup><xref ref-type="bibr" rid="ref-142">142</xref>,
<xref ref-type="bibr" rid="ref-143">143</xref></sup>, highlighting the critical nature of this epigenetic mechanism in regulating the development of the oligodendrocyte lineage.</p>
<p>Another histone methyltransferase family that catalyzes arginine instead of lysine methylation, PRMTs
<sup><xref ref-type="bibr" rid="ref-144">144</xref></sup>, is also implicated in OPC differentiation. PRMT1
<sup><xref ref-type="bibr" rid="ref-58">58</xref></sup> and PRMT5
<sup><xref ref-type="bibr" rid="ref-59">59</xref>–
<xref ref-type="bibr" rid="ref-61">61</xref></sup> have both been shown to be required for proper differentiation of OPCs into mature oligodendrocytes, and loss-of-function mutants develop hypomyelination phenotypes. The function of other PRMT family members in oligodendrocyte myelination remains to be further defined. Overall, these studies demonstrate that the balance of histone methyltransferases and histone demethylases is likely critically important for the regulation of oligodendrocyte development and remyelination.</p>
</sec>
<sec>
<title>DNA methylation and demethylation in oligodendrocyte development</title>
<p>DNA methylation is an epigenetic regulatory mechanism where cytosines, specifically those preceding guanine in so-called CpG islands, are methylated. CpG islands are preferentially found in the 5′ promotor region of genes and their methylation state can inhibit or promote the expression of the relevant gene
<sup><xref ref-type="bibr" rid="ref-145">145</xref></sup>. The methylation status of these sites is regulated by the coordinated activity of DNA methyltransferases (DNMTs), which add methyl groups to convert cytosine into 5-methylcytosine, and ten-eleven translocation (TET) proteins or DNA demethylases, which catalyze the conversion of 5-methylcytosine to 5-hydroxymethylcytosine (5hmC), beginning the process of converting 5-methylcytosine back to cytosine
<sup><xref ref-type="bibr" rid="ref-146">146</xref></sup>. The expression of individual DNMTs and TETs varies across the OL lineage, suggesting a potential stage-specific role of DNMTs and TETs for oligodendrocyte development, myelination, and remyelination. In line with these observations, there was also a significant increase in DNA methylation during OL maturation
<sup><xref ref-type="bibr" rid="ref-62">62</xref></sup>.</p>
<p>DMNT1 is downregulated during oligodendrocyte differentiation where other DMNT family members had no change
<sup><xref ref-type="bibr" rid="ref-62">62</xref></sup>. Deletion of
<italic>Dmnt1</italic> early in the oligodendrocyte lineage had a profound effect on oligodendrocyte differentiation, resulting in hypomyelination
<italic>in vivo</italic>
<sup><xref ref-type="bibr" rid="ref-62">62</xref></sup>. This effect was not due to the upregulation of normally methylated genes alone; defects in alternative splicing mediated by DNA methylation were also attributed to the failure in myelination
<sup><xref ref-type="bibr" rid="ref-62">62</xref></sup>. In contrast to the
<italic>Dmnt1</italic> knockout,
<italic>Dmnt3a</italic> knockout in NPCs had no effect
<sup><xref ref-type="bibr" rid="ref-62">62</xref></sup>. However, after lysolecithin-induced demyelination, tamoxifen-inducible
<italic>Dnmt3a</italic> deletion in mature oligodendrocytes using a PLP-CreERT2 driver line impaired remyelination whereas the inducible
<italic>Dnmt1</italic> knockout had no effect
<sup><xref ref-type="bibr" rid="ref-147">147</xref></sup>. Taken together, these results suggest that in some cases remyelination in adulthood does not fully recapitulate the developmental program.</p>
<p>TET1, TET2, and TET3 have all been implicated in the differentiation of oligodendrocytes
<italic>in vitro</italic>
<sup><xref ref-type="bibr" rid="ref-63">63</xref></sup>. However, they each have different structures and their expression and subcellular localizations differ
<sup><xref ref-type="bibr" rid="ref-63">63</xref></sup>, suggesting that they may play different roles in regulating oligodendrocyte differentiation. TET1 is downregulated in mature oligodendrocytes, TET2 translocates from the cytoplasm to the nucleus during OPC differentiation, and TET3 is seen only in the nucleus of maturing oligodendrocytes
<sup><xref ref-type="bibr" rid="ref-63">63</xref></sup>. Of these, TET1 appears to show the strongest effect in regulating the oligodendrocyte lineage where the knockout impairs oligodendrocyte development and remyelination after lysolecithin-induced demyelination
<sup><xref ref-type="bibr" rid="ref-148">148</xref>,
<xref ref-type="bibr" rid="ref-149">149</xref></sup>.</p>
</sec>
<sec>
<title>Non-coding RNAs in oligodendrocyte development and myelination</title>
<p>Non-coding RNAs such as microRNAs (miRNAs) or long-non-coding RNAs (lncRNAs) play regulatory roles in oligodendrocyte development, myelination, and remyelination. miRNAs are short RNA sequences that bind to homologous sequences on mRNA transcripts to inhibit translation into proteins. These miRNAs are processed into their mature active form by the enzyme Dicer. Conditional deletions of Dicer in OPCs and mature oligodendrocytes have all resulted in defects in myelination. Despite the myelin defects, the population of proliferating OPCs is increased in these animals, indicating a critical role for miRNAs in balancing OPC proliferation and differentiation
<sup><xref ref-type="bibr" rid="ref-64">64</xref>–
<xref ref-type="bibr" rid="ref-66">66</xref></sup>. Post-natal Dicer1 ablation in mature oligodendrocytes results in demyelination and oxidative damage, leading to neuronal degeneration and inflammatory astrogliosis and microgliosis in the brain
<sup><xref ref-type="bibr" rid="ref-64">64</xref></sup>, suggesting a critical role of Dicer and thus miRNAs in myelin lipid maintenance and redox homeostasis.</p>
<sec>
<title>miRNAs</title>
<p>Comparisons between OPCs and immature and mature oligodendrocytes revealed a set of miRNAs enriched during oligodendrocyte differentiation, including miR-219, miR-138, and miR-338
<sup><xref ref-type="bibr" rid="ref-64">64</xref>–
<xref ref-type="bibr" rid="ref-66">66</xref>,
<xref ref-type="bibr" rid="ref-150">150</xref></sup>. miR-219 is necessary and sufficient to induce differentiation and can even partially rescue the Dicer knockout phenotype
<sup><xref ref-type="bibr" rid="ref-65">65</xref>,
<xref ref-type="bibr" rid="ref-66">66</xref></sup>. Knockout of miR-219–encoding genes (
<italic>miR-219-1</italic> and
<italic>miR-219-2</italic>) led to reduced myelination throughout the CNS
<sup><xref ref-type="bibr" rid="ref-67">67</xref></sup>. In contrast to miR-219, miR-338 is dispensable for OPC differentiation or myelination
<italic>in vivo</italic>. However, there was a synergistic effect on the myelination defects in miR-219 and miR-338 double-conditional knockout mice. miR-219 is also required for remyelination after LPC-induced demyelination. Overexpression of miR-219 in OPCs increased oligodendrocyte differentiation and could even promote repair when overexpressed genetically or administered with intrathecal injections of miR-219 mimics
<sup><xref ref-type="bibr" rid="ref-67">67</xref></sup>. miR-219 likely functions by repressing inhibitors of OPC differentiation, including Lingo1 and Etv5
<sup><xref ref-type="bibr" rid="ref-67">67</xref></sup>. miR-219 has been suggested in zebrafish to regulate oligodendrocyte lineage specification from NPCs
<sup><xref ref-type="bibr" rid="ref-151">151</xref></sup>. However, there were no defects of OPC specification in the
<italic>miR-219-1/2</italic> double-null animals
<sup><xref ref-type="bibr" rid="ref-67">67</xref></sup>, suggesting a species-specific effect. Other miRNAs have been associated with oligodendrocyte development (reviewed in more detail in
<xref ref-type="bibr" rid="ref-152">152</xref>), but of these miR-219 exhibits the strongest effects.</p>
<p>A set of miRNAs have been identified to negatively regulate oligodendrocyte differentiation. One of these, miR-212 was found to be downregulated in oligodendrocytes after spinal cord injuries in rats, where it appears to repress expression of differentiation-associated genes
<sup><xref ref-type="bibr" rid="ref-68">68</xref></sup>. Another such miRNA, miR-125a-3p, was enriched in cerebrospinal fluid from MS patients with active demyelinating lesions. miR-125a-3p overexpression impaired oligodendrocyte differentiation whereas knocking it down promoted differentiation
<sup><xref ref-type="bibr" rid="ref-69">69</xref></sup>. Similarly, overexpression of miR-27a inhibits oligodendrocyte differentiation and myelination by activating the Wnt/beta-catenin signaling pathway
<sup><xref ref-type="bibr" rid="ref-153">153</xref></sup>. Such negative regulatory miRNAs are potential targets for enhancing remyelination.</p>
</sec>
<sec>
<title>LncRNAs</title>
<p>LncRNAs are long RNA sequences (more than 200 nucleotides) that are highly conserved across species but have no coding potential
<sup><xref ref-type="bibr" rid="ref-154">154</xref></sup>. LncRNAs have been implicated in the regulation of both normal development
<sup><xref ref-type="bibr" rid="ref-155">155</xref>,
<xref ref-type="bibr" rid="ref-156">156</xref></sup> and diseases
<sup><xref ref-type="bibr" rid="ref-157">157</xref>,
<xref ref-type="bibr" rid="ref-158">158</xref></sup>. LncRNAs can be very specifically expressed in the oligodendrocyte lineage; for instance,
<italic>lncOL1</italic> and
<italic>Pcdh17it</italic> were recently identified as specific markers for oligodendrocytes and immature premyelinating oligodendrocytes, respectively
<sup><xref ref-type="bibr" rid="ref-56">56</xref>,
<xref ref-type="bibr" rid="ref-71">71</xref></sup>. Gene-chip microarrays were initially used to identify lncRNAs such as SOX8OT (SOX8 opposite transcript) in cultured OPCs. SOX8OT might have a role in regulating oligodendrocyte differentiation through its regulation of SOX8
<sup><xref ref-type="bibr" rid="ref-72">72</xref>,
<xref ref-type="bibr" rid="ref-73">73</xref></sup>.</p>
<p>Combining RNA sequencing and chromatin mapping across oligodendrocyte lineage stages revealed several lncRNAs that are actively transcribed and restricted to this lineage
<sup><xref ref-type="bibr" rid="ref-56">56</xref></sup>. Of these,
<italic>lncOL1</italic> was identified as a top candidate on the basis of its abundance, regulation during oligodendrocyte differentiation, and preliminary screening for effects on myelin-associated gene expression.
<italic>lncOL1</italic> overexpression led to precocious oligodendrocyte differentiation in mouse embryos, and
<italic>lncOL1</italic> knockout led to defects in OPC differentiation while having no effect on OPC formation. Interestingly, these myelination defects were seen only during development but not in adulthood, suggesting a role of
<italic>lncOL1</italic> in regulating the timing of myelinogenesis and not the maintenance of myelin.
<italic>lncOL1</italic> mediates this effect in part by its interaction with SUZ12, a member of the PRC2 complex which mediates histone methylation through EZH2.
<italic>lncOL1</italic> directs the PRC2 complex to silence the expression of OPC-associated genes via H3K27me3 deposition
<sup><xref ref-type="bibr" rid="ref-56">56</xref></sup>. In contrast to
<italic>lncOL1</italic>,
<italic>lnc-OPC</italic>, another lncRNA found in the oligodendrocyte lineage, is enriched in OPCs and regulated by OLIG2
<sup><xref ref-type="bibr" rid="ref-70">70</xref></sup>. Knockdown of
<italic>lnc-OPC</italic> in cultured NPCs limited their differentiation into OPCs without affecting NPC proliferation
<sup><xref ref-type="bibr" rid="ref-70">70</xref></sup>. In similar fashion,
<italic>lnc158</italic> expression directly correlated with oligodendrocyte-associated protein expression and differentiation along the oligodendrocyte lineage
<sup><xref ref-type="bibr" rid="ref-75">75</xref></sup>. In addition, another lncRNA,
<italic>Neat1</italic>, was downregulated in schizophrenia.
<italic>Neat1</italic> knockout mice exhibited a reduction in the number of oligodendrocytes in the frontal cortex because of a failure in the retention of oligodendrocyte transcription factors in the nucleus
<sup><xref ref-type="bibr" rid="ref-74">74</xref></sup>. These studies indicate that lncRNAs regulate oligodendrocyte development and myelination via various processes such as controlling mRNA transcripts, nuclear localization of transcription factors, or interactions with chromatin remodelers.</p>
</sec>
</sec>
<sec>
<title>m
<sup>6</sup>A RNA modification in oligodendrocyte progression and homeostasis</title>
<p>
<italic>N</italic>
<sup>6</sup>-methyladenosine (m
<sup>6</sup>A) is the most abundant internal modification of mRNA in eukaryotes. A methyl group can be added to the N
<sup>6</sup> position of adenosines in specific sequences by m
<sup>6</sup>A methyltransferases (m
<sup>6</sup>A writers) such as METTL3 and METTL14 or removed by demethylases (m
<sup>6</sup>A erasers) such as FTO and ALKBH5. The effects of m
<sup>6</sup>A methylation on translation and RNA stability is mediated by m
<sup>6</sup>A-specific binding proteins (m
<sup>6</sup>A readers) including YTH-domain containing family proteins, hnRNP proteins, PRRC2A, and IGF2BP
<sup><xref ref-type="bibr" rid="ref-159">159</xref>–
<xref ref-type="bibr" rid="ref-161">161</xref></sup>.</p>
<p>Recent studies have revealed a differential m
<sup>6</sup>A methylation of core oligodendrocyte lineage genes during OPC differentiation, suggesting an important role for this process in OL differentiation
<sup><xref ref-type="bibr" rid="ref-76">76</xref></sup>. Deleting the METTL14 led to defects in OPC differentiation and hypomyelination at least in part by regulating alternative mRNA splicing in OL-expressing genes, including the paranodal protein NF155, which is critical for the establishment and maintenance of nodes of Ranvier
<sup><xref ref-type="bibr" rid="ref-76">76</xref></sup>. In addition, the m
<sup>6</sup>A RNA binding protein PRRC2A is highly expressed in OPCs during development in the white matter tracks. Both knockout and knockdown of PRRC2A in NPCs via
<italic>Nestin-Cre</italic> or
<italic>Olig2-Cre</italic>
<sup>+</sup> oligodendrocyte lineage cells led to hypomyelination due to defects in OPC proliferation and differentiation
<sup><xref ref-type="bibr" rid="ref-77">77</xref></sup>. PRRC2A was shown to bind to the
<italic>Olig2</italic> mRNA and further stabilize the expression of
<italic>Olig2</italic> transcript in an m
<sup>6</sup>A-dependent manner. Knocking out the RNA demethylase FTO mimicked the effects of PRRC2A overexpression
<sup><xref ref-type="bibr" rid="ref-77">77</xref></sup> and led to increased
<italic>Olig2</italic> expression levels. These studies suggest a critical role for m
<sup>6</sup>A modification in the OL myelination process. The function of other mRNA modification enzymes remains to be determined in myelination and remyelination in the CNS.</p>
</sec>
<sec sec-type="conclusions">
<title>Conclusion and perspectives</title>
<p>Chromatin modifications and epigenetic regulation are crucial for oligodendrocyte fate specification, OPC proliferation, and oligodendrocyte differentiation (
<xref ref-type="fig" rid="f1">Figure 1</xref>). Many members of chromatin modifiers discussed above have not yet been examined in the context of oligodendrocyte development and regeneration. In particular, although the major mediators of these developmental processes are being identified, the environmental influences that modulate the epigenetic mechanisms are very poorly understood. A better understanding of the mechanisms underlying the windows of epigenetic engagement will facilitate oligodendrocyte regeneration and remyelination.</p>
<p>Targeting epigenetic factors to influence OPC differentiation as a means to promote myelin regeneration after nerve injury or in demyelinating diseases is an exciting potential therapeutic avenue. In MS, for example, many demyelinating plaques still contain OPCs; however, these cells fail to differentiate to replace those lost. Additionally, oligodendrocyte loss and the subsequent loss of myelin sheaths have been implicated in Alzheimer’s disease
<sup><xref ref-type="bibr" rid="ref-55">55</xref>,
<xref ref-type="bibr" rid="ref-92">92</xref>,
<xref ref-type="bibr" rid="ref-162">162</xref>,
<xref ref-type="bibr" rid="ref-163">163</xref></sup>. Stimulating OPCs to proliferate and differentiate would be an exciting treatment option in slowing the disease progression.</p>
<p>In the future, it may prove fruitful to further scrutinize
<italic>in vivo</italic> models of demyelinating diseases for temporal changes in chromatin landscape, structure, occupancy, and activity in response to myelin-promoting stimuli or pharmacological treatments, such as those used in MS disease-modifying therapies. Future work of exploring these various family members of chromatin modifiers and identifying specific epigenetic modifiers responsible for CNS myelination and remyelination will facilitate the development of effective treatments for developmental disorders and neurodegenerative diseases.</p>
</sec>
</body>
<back>
<ref-list>
<ref id="ref-1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Simons</surname><given-names>M</given-names></name><name><surname>Nave</surname><given-names>KA</given-names></name></person-group>:
<article-title>Oligodendrocytes: Myelination and Axonal Support.</article-title>
<source/><italic toggle="yes">Cold Spring Harb Perspect Biol.</italic>
<year>2015</year>;<volume>8</volume>(<issue>1</issue>):<fpage>a020479</fpage>.
<pub-id pub-id-type="doi">10.1101/cshperspect.a020479</pub-id>
<!--<pub-id pub-id-type="pmcid">4691794</pub-id>-->
<pub-id pub-id-type="pmid">26101081</pub-id></mixed-citation>
</ref>
<ref id="ref-2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boddaert</surname><given-names>N</given-names></name><name><surname>Zilbovicius</surname><given-names>M</given-names></name><name><surname>Philipe</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>MRI findings in 77 children with non-syndromic autistic disorder.</article-title>
<source/><italic toggle="yes">PLoS One.</italic>
<year>2009</year>;<volume>4</volume>(<issue>2</issue>):<fpage>e4415</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0004415</pub-id>
<!--<pub-id pub-id-type="pmcid">2635956</pub-id>-->
<pub-id pub-id-type="pmid">19204795</pub-id></mixed-citation>
</ref>
<ref id="ref-3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Casanova</surname><given-names>MF</given-names></name></person-group>:
<article-title>Neuropathological and genetic findings in autism: the significance of a putative minicolumnopathy.</article-title>
<source/><italic toggle="yes">Neuroscientist.</italic>
<year>2006</year>;<volume>12</volume>(<issue>5</issue>):<fpage>435</fpage>–<lpage>41</lpage>.
<pub-id pub-id-type="doi">10.1177/1073858406290375</pub-id>
<pub-id pub-id-type="pmid">16957005</pub-id></mixed-citation>
</ref>
<ref id="ref-4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Deoni</surname><given-names>SCL</given-names></name><name><surname>Zinkstok</surname><given-names>JR</given-names></name><name><surname>Daly</surname><given-names>E</given-names></name><etal></etal></person-group>:
<article-title>White-matter relaxation time and myelin water fraction differences in young adults with autism.</article-title>
<source/><italic toggle="yes">Psychol Med.</italic>
<year>2015</year>;<volume>45</volume>(<issue>4</issue>):<fpage>795</fpage>–<lpage>805</lpage>.
<pub-id pub-id-type="doi">10.1017/S0033291714001858</pub-id>
<pub-id pub-id-type="pmid">25111948</pub-id></mixed-citation>
</ref>
<ref id="ref-5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hardan</surname><given-names>AY</given-names></name><name><surname>Fung</surname><given-names>LK</given-names></name><name><surname>Frazier</surname><given-names>T</given-names></name><etal></etal></person-group>:
<article-title>A proton spectroscopy study of white matter in children with autism.</article-title>
<source/><italic toggle="yes">Prog Neuropsychopharmacol Biol Psychiatry.</italic>
<year>2016</year>;<volume>66</volume>:<fpage>48</fpage>–<lpage>53</lpage>.
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2015.11.005</pub-id>
<!--<pub-id pub-id-type="pmcid">4728039</pub-id>-->
<pub-id pub-id-type="pmid">26593330</pub-id></mixed-citation>
</ref>
<ref id="ref-6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>D</given-names></name><name><surname>Marie</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><etal></etal></person-group>:
<article-title>Chd7 cooperates with Sox10 and regulates the onset of CNS myelination and remyelination.</article-title>
<source/><italic toggle="yes">Nat Neurosci.</italic>
<year>2016</year>;<volume>19</volume>(<issue>5</issue>):<fpage>678</fpage>–<lpage>89</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.4258</pub-id>
<!--<pub-id pub-id-type="pmcid">4846514</pub-id>-->
<pub-id pub-id-type="pmid">26928066</pub-id></mixed-citation>
</ref>
<ref id="ref-7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gregory</surname><given-names>LC</given-names></name><name><surname>Gevers</surname><given-names>EF</given-names></name><name><surname>Baker</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Structural pituitary abnormalities associated with CHARGE syndrome.</article-title>
<source/><italic toggle="yes">J Clin Endocrinol Metab.</italic>
<year>2013</year>;<volume>98</volume>(<issue>4</issue>):<fpage>E737</fpage>–<lpage>43</lpage>.
<pub-id pub-id-type="doi">10.1210/jc.2012-3467</pub-id>
<!--<pub-id pub-id-type="pmcid">3708033</pub-id>-->
<pub-id pub-id-type="pmid">23526466</pub-id></mixed-citation>
</ref>
<ref id="ref-8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Popescu</surname><given-names>BF</given-names></name><name><surname>Lucchinetti</surname><given-names>CF</given-names></name></person-group>:
<article-title>Pathology of demyelinating diseases.</article-title>
<source/><italic toggle="yes">Annu Rev Pathol.</italic>
<year>2012</year>;<volume>7</volume>:<fpage>185</fpage>–<lpage>217</lpage>.
<pub-id pub-id-type="doi">10.1146/annurev-pathol-011811-132443</pub-id>
<pub-id pub-id-type="pmid">22313379</pub-id></mixed-citation>
</ref>
<ref id="ref-9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huse</surname><given-names>JT</given-names></name><name><surname>Holland</surname><given-names>EC</given-names></name></person-group>:
<article-title>Targeting brain cancer: Advances in the molecular pathology of malignant glioma and medulloblastoma.</article-title>
<source/><italic toggle="yes">Nat Rev Cancer.</italic>
<year>2010</year>;<volume>10</volume>(<issue>5</issue>):<fpage>319</fpage>–<lpage>31</lpage>.
<pub-id pub-id-type="doi">10.1038/nrc2818</pub-id>
<pub-id pub-id-type="pmid">20414201</pub-id></mixed-citation>
</ref>
<ref id="ref-10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bei</surname><given-names>F</given-names></name><name><surname>Lee</surname><given-names>HHC</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><etal></etal></person-group>:
<article-title>Restoration of Visual Function by Enhancing Conduction in Regenerated Axons.</article-title>
<source/><italic toggle="yes">Cell.</italic>
<year>2016</year>;<volume>164</volume>(<issue>1-2</issue>):<fpage>219</fpage>–<lpage>32</lpage>.
<pub-id pub-id-type="doi">10.1016/j.cell.2015.11.036</pub-id>
<!--<pub-id pub-id-type="pmcid">4863988</pub-id>-->
<pub-id pub-id-type="pmid">26771493</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726076739">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Franklin</surname><given-names>RJ</given-names></name><name><surname>Gallo</surname><given-names>V</given-names></name></person-group>:
<article-title>The translational biology of remyelination: Past, present, and future.</article-title>
<source/><italic toggle="yes">Glia.</italic>
<year>2014</year>;<volume>62</volume>(<issue>11</issue>):<fpage>1905</fpage>–<lpage>15</lpage>.
<pub-id pub-id-type="doi">10.1002/glia.22622</pub-id>
<pub-id pub-id-type="pmid">24446279</pub-id></mixed-citation>
</ref>
<ref id="ref-12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Queme</surname><given-names>LF</given-names></name><etal></etal></person-group>:
<article-title>A histone deacetylase 3-dependent pathway delimits peripheral myelin growth and functional regeneration.</article-title>
<source/><italic toggle="yes">Nat Med.</italic>
<year>2018</year>;<volume>24</volume>(<issue>3</issue>):<fpage>338</fpage>–<lpage>51</lpage>.
<pub-id pub-id-type="doi">10.1038/nm.4483</pub-id>
<!--<pub-id pub-id-type="pmcid">5908710</pub-id>-->
<pub-id pub-id-type="pmid">29431744</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/732646481">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-13">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Toosy</surname><given-names>AT</given-names></name><name><surname>Mason</surname><given-names>DF</given-names></name><name><surname>Miller</surname><given-names>DH</given-names></name></person-group>:
<article-title>Optic neuritis.</article-title>
<source/><italic toggle="yes">The Lancet Neurology.</italic>
<year>2014</year>;<volume>13</volume>(<issue>1</issue>):<fpage>83</fpage>–<lpage>99</lpage>.
<pub-id pub-id-type="doi">10.1016/S1474-4422(13)70259-X</pub-id>
<pub-id pub-id-type="pmid">24331795</pub-id></mixed-citation>
</ref>
<ref id="ref-14">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lopez Juarez</surname><given-names>A</given-names></name><name><surname>He</surname><given-names>D</given-names></name><name><surname>Richard Lu</surname><given-names>Q</given-names></name></person-group>:
<article-title>Oligodendrocyte progenitor programming and reprogramming: Toward myelin regeneration.</article-title>
<source/><italic toggle="yes">Brain Res.</italic>
<year>2016</year>;<volume>1638</volume>(<issue>Pt B</issue>):<fpage>209</fpage>–<lpage>20</lpage>.
<pub-id pub-id-type="doi">10.1016/j.brainres.2015.10.051</pub-id>
<!--<pub-id pub-id-type="pmcid">5119932</pub-id>-->
<pub-id pub-id-type="pmid">26546966</pub-id></mixed-citation>
</ref>
<ref id="ref-15">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goldman</surname><given-names>SA</given-names></name><name><surname>Kuypers</surname><given-names>NJ</given-names></name></person-group>:
<article-title>How to make an oligodendrocyte.</article-title>
<source/><italic toggle="yes">Development.</italic>
<year>2015</year>;<volume>142</volume>(<issue>23</issue>):<fpage>3983</fpage>–<lpage>95</lpage>.
<pub-id pub-id-type="doi">10.1242/dev.126409</pub-id>
<pub-id pub-id-type="pmid">26628089</pub-id></mixed-citation>
</ref>
<ref id="ref-16">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kessaris</surname><given-names>N</given-names></name><name><surname>Fogarty</surname><given-names>M</given-names></name><name><surname>Iannarelli</surname><given-names>P</given-names></name><etal></etal></person-group>:
<article-title>Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage.</article-title>
<source/><italic toggle="yes">Nat Neurosci.</italic>
<year>2006</year>;<volume>9</volume>(<issue>2</issue>):<fpage>173</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1038/nn1620</pub-id>
<!--<pub-id pub-id-type="pmcid">6328015</pub-id>-->
<pub-id pub-id-type="pmid">16388308</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1030668">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-17">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dawson</surname><given-names>MR</given-names></name><name><surname>Polito</surname><given-names>A</given-names></name><name><surname>Levine</surname><given-names>JM</given-names></name><etal></etal></person-group>:
<article-title>NG2-expressing glial progenitor cells: An abundant and widespread population of cycling cells in the adult rat CNS.</article-title>
<source/><italic toggle="yes">Mol Cell Neurosci.</italic>
<year>2003</year>;<volume>24</volume>(<issue>2</issue>):<fpage>476</fpage>–<lpage>88</lpage>.
<pub-id pub-id-type="doi">10.1016/s1044-7431(03)00210-0</pub-id>
<pub-id pub-id-type="pmid">14572468</pub-id></mixed-citation>
</ref>
<ref id="ref-18">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zuchero</surname><given-names>JB</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name></person-group>:
<article-title>Intrinsic and extrinsic control of oligodendrocyte development.</article-title>
<source/><italic toggle="yes">Curr Opin Neurobiol.</italic>
<year>2013</year>;<volume>23</volume>(<issue>6</issue>):<fpage>914</fpage>–<lpage>20</lpage>.
<pub-id pub-id-type="doi">10.1016/j.conb.2013.06.005</pub-id>
<!--<pub-id pub-id-type="pmcid">4431975</pub-id>-->
<pub-id pub-id-type="pmid">23831087</pub-id></mixed-citation>
</ref>
<ref id="ref-19">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Emery</surname><given-names>B</given-names></name></person-group>:
<article-title>Transcriptional and post-transcriptional control of CNS myelination.</article-title>
<source/><italic toggle="yes">Curr Opin Neurobiol.</italic>
<year>2010</year>;<volume>20</volume>(<issue>5</issue>):<fpage>601</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1016/j.conb.2010.05.005</pub-id>
<pub-id pub-id-type="pmid">20558055</pub-id></mixed-citation>
</ref>
<ref id="ref-20">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wegner</surname><given-names>M</given-names></name></person-group>:
<article-title>A matter of identity: transcriptional control in oligodendrocytes.</article-title>
<source/><italic toggle="yes">J Mol Neurosci.</italic>
<year>2008</year>;<volume>35</volume>(<issue>1</issue>):<fpage>3</fpage>–<lpage>12</lpage>.
<pub-id pub-id-type="doi">10.1007/s12031-007-9008-8</pub-id>
<pub-id pub-id-type="pmid">18401762</pub-id></mixed-citation>
</ref>
<ref id="ref-21">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bird</surname><given-names>A</given-names></name></person-group>:
<article-title>Perceptions of epigenetics.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2007</year>;<volume>447</volume>(<issue>7143</issue>):<fpage>396</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1038/nature05913</pub-id>
<pub-id pub-id-type="pmid">17522671</pub-id></mixed-citation>
</ref>
<ref id="ref-22">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gibson</surname><given-names>EM</given-names></name><name><surname>Purger</surname><given-names>D</given-names></name><name><surname>Mount</surname><given-names>CW</given-names></name><etal></etal></person-group>:
<article-title>Neuronal Activity Promotes Oligodendrogenesis and Adaptive Myelination in the Mammalian Brain.</article-title>
<source/><italic toggle="yes">Science.</italic>
<year>2014</year>;<volume>344</volume>(<issue>6183</issue>):<fpage>1252304</fpage>.
<pub-id pub-id-type="doi">10.1126/science.1252304</pub-id>
<!--<pub-id pub-id-type="pmcid">4096908</pub-id>-->
<pub-id pub-id-type="pmid">24727982</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718348469">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-23">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zatorre</surname><given-names>RJ</given-names></name><name><surname>Fields</surname><given-names>RD</given-names></name><name><surname>Johansen-Berg</surname><given-names>H</given-names></name></person-group>:
<article-title>Plasticity in gray and white: Neuroimaging changes in brain structure during learning.</article-title>
<source/><italic toggle="yes">Nat Neurosci.</italic>
<year>2012</year>;<volume>15</volume>(<issue>4</issue>):<fpage>528</fpage>–<lpage>36</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.3045</pub-id>
<!--<pub-id pub-id-type="pmcid">3660656</pub-id>-->
<pub-id pub-id-type="pmid">22426254</pub-id></mixed-citation>
</ref>
<ref id="ref-24">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scholz</surname><given-names>J</given-names></name><name><surname>Klein</surname><given-names>MC</given-names></name><name><surname>Behrens</surname><given-names>TE</given-names></name><etal></etal></person-group>:
<article-title>Training induces changes in white-matter architecture.</article-title>
<source/><italic toggle="yes">Nat Neurosci.</italic>
<year>2009</year>;<volume>12</volume>(<issue>11</issue>):<fpage>1370</fpage>–<lpage>1</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.2412</pub-id>
<!--<pub-id pub-id-type="pmcid">2770457</pub-id>-->
<pub-id pub-id-type="pmid">19820707</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1279970">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-25">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sampaio-Baptista</surname><given-names>C</given-names></name><name><surname>Khrapitchev</surname><given-names>AA</given-names></name><name><surname>Foxley</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Motor Skill Learning Induces Changes in White Matter Microstructure and Myelination.</article-title>
<source/><italic toggle="yes">J Neurosci.</italic>
<year>2013</year>;<volume>33</volume>(<issue>50</issue>):<fpage>19499</fpage>–<lpage>503</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3048-13.2013</pub-id>
<!--<pub-id pub-id-type="pmcid">3858622</pub-id>-->
<pub-id pub-id-type="pmid">24336716</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718203202">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-26">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McKenzie</surname><given-names>IA</given-names></name><name><surname>Ohayon</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>Motor skill learning requires active central myelination.</article-title>
<source/><italic toggle="yes">Science.</italic>
<year>2014</year>;<volume>346</volume>(<issue>6207</issue>):<fpage>318</fpage>–<lpage>22</lpage>.
<pub-id pub-id-type="doi">10.1126/science.1254960</pub-id>
<!--<pub-id pub-id-type="pmcid">6324726</pub-id>-->
<pub-id pub-id-type="pmid">25324381</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/722496230">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-27">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mangin</surname><given-names>JM</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Scafidi</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Experience-dependent regulation of NG2 progenitors in the developing barrel cortex.</article-title>
<source/><italic toggle="yes">Nat Neurosci.</italic>
<year>2012</year>;<volume>15</volume>(<issue>9</issue>):<fpage>1192</fpage>–<lpage>4</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.3190</pub-id>
<!--<pub-id pub-id-type="pmcid">3437334</pub-id>-->
<pub-id pub-id-type="pmid">22885848</pub-id></mixed-citation>
</ref>
<ref id="ref-28">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bengtsson</surname><given-names>SL</given-names></name><name><surname>Nagy</surname><given-names>Z</given-names></name><name><surname>Skare</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Extensive piano practicing has regionally specific effects on white matter development.</article-title>
<source/><italic toggle="yes">Nat Neurosci.</italic>
<year>2005</year>;<volume>8</volume>(<issue>9</issue>):<fpage>1148</fpage>–<lpage>50</lpage>.
<pub-id pub-id-type="doi">10.1038/nn1516</pub-id>
<pub-id pub-id-type="pmid">16116456</pub-id></mixed-citation>
</ref>
<ref id="ref-29">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barrera</surname><given-names>K</given-names></name><name><surname>Chu</surname><given-names>P</given-names></name><name><surname>Abramowitz</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Organization of myelin in the mouse somatosensory barrel cortex and the effects of sensory deprivation.</article-title>
<source/><italic toggle="yes">Dev Neurobiol.</italic>
<year>2013</year>;<volume>73</volume>(<issue>4</issue>):<fpage>297</fpage>–<lpage>314</lpage>.
<pub-id pub-id-type="doi">10.1002/dneu.22060</pub-id>
<!--<pub-id pub-id-type="pmcid">3725810</pub-id>-->
<pub-id pub-id-type="pmid">23047707</pub-id></mixed-citation>
</ref>
<ref id="ref-30">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Makinodan</surname><given-names>M</given-names></name><name><surname>Rosen</surname><given-names>KM</given-names></name><name><surname>Ito</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>A critical period for social experience-dependent oligodendrocyte maturation and myelination.</article-title>
<source/><italic toggle="yes">Science.</italic>
<year>2012</year>;<volume>337</volume>(<issue>6100</issue>):<fpage>1357</fpage>–<lpage>60</lpage>.
<pub-id pub-id-type="doi">10.1126/science.1220845</pub-id>
<!--<pub-id pub-id-type="pmcid">4165613</pub-id>-->
<pub-id pub-id-type="pmid">22984073</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/717965116">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-31">
<label>31</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Dietz</surname><given-names>K</given-names></name><name><surname>DeLoyht</surname><given-names>JM</given-names></name><etal></etal></person-group>:
<article-title>Impaired adult myelination in the prefrontal cortex of socially isolated mice.</article-title>
<source/><italic toggle="yes">Nat Neurosci.</italic>
<year>2012</year>;<volume>15</volume>(<issue>12</issue>):<fpage>1621</fpage>–<lpage>3</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.3263</pub-id>
<!--<pub-id pub-id-type="pmcid">3729624</pub-id>-->
<pub-id pub-id-type="pmid">23143512</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/717963415">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-32">
<label>32</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Purger</surname><given-names>D</given-names></name><name><surname>Gibson</surname><given-names>EM</given-names></name><name><surname>Monje</surname><given-names>M</given-names></name></person-group>:
<article-title>Myelin plasticity in the central nervous system.</article-title>
<source/><italic toggle="yes">Neuropharmacology.</italic>
<year>2016</year>;<volume>110</volume>(<issue>Pt B</issue>):<fpage>563</fpage>–<lpage>73</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2015.08.001</pub-id>
<pub-id pub-id-type="pmid">26282119</pub-id></mixed-citation>
</ref>
<ref id="ref-33">
<label>33</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Monje</surname><given-names>M</given-names></name></person-group>:
<article-title>Myelin Plasticity and Nervous System Function.</article-title>
<source/><italic toggle="yes">Annu Rev Neurosci.</italic>
<year>2018</year>;<volume>41</volume>:<fpage>61</fpage>–<lpage>76</lpage>.
<pub-id pub-id-type="doi">10.1146/annurev-neuro-080317-061853</pub-id>
<pub-id pub-id-type="pmid">29986163</pub-id></mixed-citation>
</ref>
<ref id="ref-34">
<label>34</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Emery</surname><given-names>B</given-names></name><name><surname>Lu</surname><given-names>QR</given-names></name></person-group>:
<article-title>Transcriptional and Epigenetic Regulation of Oligodendrocyte Development and Myelination in the Central Nervous System.</article-title>
<source/><italic toggle="yes">Cold Spring Harb Perspect Biol.</italic>
<year>2015</year>;<volume>7</volume>(<issue>9</issue>):<fpage>a020461</fpage>.
<pub-id pub-id-type="doi">10.1101/cshperspect.a020461</pub-id>
<!--<pub-id pub-id-type="pmcid">4563712</pub-id>-->
<pub-id pub-id-type="pmid">26134004</pub-id></mixed-citation>
</ref>
<ref id="ref-35">
<label>35</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>LO</given-names></name><name><surname>Mulinyawe</surname><given-names>SB</given-names></name><name><surname>Collins</surname><given-names>HY</given-names></name><etal></etal></person-group>:
<article-title>Spatiotemporal Control of CNS Myelination by Oligodendrocyte Programmed Cell Death through the TFEB-PUMA Axis.</article-title>
<source/><italic toggle="yes">Cell.</italic>
<year>2018</year>;<volume>175</volume>(<issue>7</issue>):<fpage>1811</fpage>–<lpage>1826.e21</lpage>.
<pub-id pub-id-type="doi">10.1016/j.cell.2018.10.044</pub-id>
<!--<pub-id pub-id-type="pmcid">6295215</pub-id>-->
<pub-id pub-id-type="pmid">30503207</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/734515510">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-36">
<label>36</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>B</given-names></name><etal></etal></person-group>:
<article-title>Olig2 Targets Chromatin Remodelers to Enhancers to Initiate Oligodendrocyte Differentiation.</article-title>
<source/><italic toggle="yes">Cell.</italic>
<year>2013</year>;<volume>152</volume>(1–2):<fpage>248</fpage>–<lpage>61</lpage>.
<pub-id pub-id-type="doi">10.1016/j.cell.2012.12.006</pub-id>
<!--<pub-id pub-id-type="pmcid">3553550</pub-id>-->
<pub-id pub-id-type="pmid">23332759</pub-id></mixed-citation>
</ref>
<ref id="ref-37">
<label>37</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bischof</surname><given-names>M</given-names></name><name><surname>Weider</surname><given-names>M</given-names></name><name><surname>Küspert</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Brg1-dependent chromatin remodelling is not essentially required during oligodendroglial differentiation.</article-title>
<source/><italic toggle="yes">J Neurosci.</italic>
<year>2015</year>;<volume>35</volume>(<issue>1</issue>):<fpage>21</fpage>–<lpage>35</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1468-14.2015</pub-id>
<!--<pub-id pub-id-type="pmcid">6605249</pub-id>-->
<pub-id pub-id-type="pmid">25568100</pub-id></mixed-citation>
</ref>
<ref id="ref-38">
<label>38</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Doi</surname><given-names>T</given-names></name><name><surname>Ogata</surname><given-names>T</given-names></name><name><surname>Yamauchi</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Chd7 Collaborates with Sox2 to Regulate Activation of Oligodendrocyte Precursor Cells after Spinal Cord Injury.</article-title>
<source/><italic toggle="yes">J Neurosci.</italic>
<year>2017</year>;<volume>37</volume>(<issue>43</issue>):<fpage>10290</fpage>–<lpage>309</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1109-17.2017</pub-id>
<!--<pub-id pub-id-type="pmcid">6596621</pub-id>-->
<pub-id pub-id-type="pmid">28931573</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/731253563">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-39">
<label>39</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marie</surname><given-names>C</given-names></name><name><surname>Clavairoly</surname><given-names>A</given-names></name><name><surname>Frah</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Oligodendrocyte precursor survival and differentiation requires chromatin remodeling by Chd7 and Chd8.</article-title>
<source/><italic toggle="yes">Proc Natl Acad Sci U S A.</italic>
<year>2018</year>;<volume>115</volume>(<issue>35</issue>):<fpage>E8246</fpage>–<lpage>E8255</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1802620115</pub-id>
<!--<pub-id pub-id-type="pmcid">6126750</pub-id>-->
<pub-id pub-id-type="pmid">30108144</pub-id></mixed-citation>
</ref>
<ref id="ref-40">
<label>40</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bernier</surname><given-names>R</given-names></name><name><surname>Golzio</surname><given-names>C</given-names></name><name><surname>Xiong</surname><given-names>B</given-names></name><etal></etal></person-group>:
<article-title>Disruptive CHD8 Mutations Define a Subtype of Autism Early in Development.</article-title>
<source/><italic toggle="yes">Cell.</italic>
<year>2014</year>;<volume>158</volume>(<issue>2</issue>):<fpage>263</fpage>–<lpage>76</lpage>.
<pub-id pub-id-type="doi">10.1016/j.cell.2014.06.017</pub-id>
<!--<pub-id pub-id-type="pmcid">4136921</pub-id>-->
<pub-id pub-id-type="pmid">24998929</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718482809">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-41">
<label>41</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Dong</surname><given-names>C</given-names></name><name><surname>Frah</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Dual Requirement of CHD8 for Chromatin Landscape Establishment and Histone Methyltransferase Recruitment to Promote CNS Myelination and Repair.</article-title>
<source/><italic toggle="yes">Dev Cell.</italic>
<year>2018</year>;<volume>45</volume>(<issue>6</issue>):<fpage>753</fpage>–<lpage>768.e8</lpage>.
<pub-id pub-id-type="doi">10.1016/j.devcel.2018.05.022</pub-id>
<!--<pub-id pub-id-type="pmcid">6063525</pub-id>-->
<pub-id pub-id-type="pmid">29920279</pub-id></mixed-citation>
</ref>
<ref id="ref-42">
<label>42</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Negri</surname><given-names>G</given-names></name><name><surname>Milani</surname><given-names>D</given-names></name><name><surname>Colapietro</surname><given-names>P</given-names></name><etal></etal></person-group>:
<article-title>Clinical and molecular characterization of Rubinstein-Taybi syndrome patients carrying distinct novel mutations of the
<italic>EP300</italic> gene.</article-title>
<source/><italic toggle="yes">Clin Genet.</italic>
<year>2015</year>;<volume>87</volume>(<issue>2</issue>):<fpage>148</fpage>–<lpage>54</lpage>.
<pub-id pub-id-type="doi">10.1111/cge.12348</pub-id>
<pub-id pub-id-type="pmid">24476420</pub-id></mixed-citation>
</ref>
<ref id="ref-43">
<label>43</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>N</given-names></name><name><surname>Acosta</surname><given-names>AM</given-names></name><name><surname>Kohlhase</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Confirmation of
<italic>EP300</italic> gene mutations as a rare cause of Rubinstein–Taybi syndrome.</article-title>
<source/><italic toggle="yes">Eur J Hum Genet.</italic>
<year>2007</year>;<volume>15</volume>(<issue>8</issue>):<fpage>837</fpage>–<lpage>42</lpage>.
<pub-id pub-id-type="doi">10.1038/sj.ejhg.5201791</pub-id>
<pub-id pub-id-type="pmid">17299436</pub-id></mixed-citation>
</ref>
<ref id="ref-44">
<label>44</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><etal></etal></person-group>:
<article-title>Hdac3 Interaction with p300 Histone Acetyltransferase Regulates the Oligodendrocyte and Astrocyte Lineage Fate Switch.</article-title>
<source/><italic toggle="yes">Dev Cell.</italic>
<year>2016</year>;<volume>36</volume>(<issue>3</issue>):<fpage>316</fpage>–<lpage>30</lpage>.
<pub-id pub-id-type="doi">10.1016/j.devcel.2016.01.002</pub-id>
<!--<pub-id pub-id-type="pmcid">4750051</pub-id>-->
<pub-id pub-id-type="pmid">26859354</pub-id></mixed-citation>
</ref>
<ref id="ref-45">
<label>45</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elsesser</surname><given-names>O</given-names></name><name><surname>Fröb</surname><given-names>F</given-names></name><name><surname>Küspert</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Chromatin remodeler Ep400 ensures oligodendrocyte survival and is required for myelination in the vertebrate central nervous system.</article-title>
<source/><italic toggle="yes">Nucleic Acids Res.</italic>
<year>2019</year>;<volume>47</volume>(<issue>2</issue>):<fpage>6208</fpage>–<lpage>24</lpage>.
<pub-id pub-id-type="doi">10.1093/nar/gkz376</pub-id>
<!--<pub-id pub-id-type="pmcid">6614847</pub-id>-->
<pub-id pub-id-type="pmid">31081019</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/735757608">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-46">
<label>46</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ye</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Hoang</surname><given-names>T</given-names></name><etal></etal></person-group>:
<article-title>HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction.</article-title>
<source/><italic toggle="yes">Nat Neurosci.</italic>
<year>2009</year>;<volume>12</volume>(<issue>7</issue>):<fpage>829</fpage>–<lpage>38</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.2333</pub-id>
<!--<pub-id pub-id-type="pmcid">2701973</pub-id>-->
<pub-id pub-id-type="pmid">19503085</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1162167">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-47">
<label>47</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><etal></etal></person-group>:
<article-title>Dual regulatory switch through interactions of Tcf7l2/Tcf4 with stage-specific partners propels oligodendroglial maturation.</article-title>
<source/><italic toggle="yes">Nat Commun.</italic>
<year>2016</year>;<volume>7</volume>:<fpage>10883</fpage>.
<pub-id pub-id-type="doi">10.1038/ncomms10883</pub-id>
<!--<pub-id pub-id-type="pmcid">4786870</pub-id>-->
<pub-id pub-id-type="pmid">26955760</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726204572">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-48">
<label>48</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hammond</surname><given-names>E</given-names></name><name><surname>Lang</surname><given-names>J</given-names></name><name><surname>Maeda</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>The Wnt effector transcription factor 7-like 2 positively regulates oligodendrocyte differentiation in a manner independent of Wnt/β-catenin signaling.</article-title>
<source/><italic toggle="yes">J Neurosci.</italic>
<year>2015</year>;<volume>35</volume>(<issue>12</issue>):<fpage>5007</fpage>–<lpage>22</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4787-14.2015</pub-id>
<!--<pub-id pub-id-type="pmcid">6705374</pub-id>-->
<pub-id pub-id-type="pmid">25810530</pub-id></mixed-citation>
</ref>
<ref id="ref-49">
<label>49</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dai</surname><given-names>J</given-names></name><name><surname>Bercury</surname><given-names>KK</given-names></name><name><surname>Jin</surname><given-names>W</given-names></name><etal></etal></person-group>:
<article-title>Olig1 Acetylation and Nuclear Export Mediate Oligodendrocyte Development.</article-title>
<source/><italic toggle="yes">J Neurosci.</italic>
<year>2015</year>;<volume>35</volume>(<issue>48</issue>):<fpage>15875</fpage>–<lpage>93</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0882-15.2015</pub-id>
<!--<pub-id pub-id-type="pmcid">4666914</pub-id>-->
<pub-id pub-id-type="pmid">26631469</pub-id></mixed-citation>
</ref>
<ref id="ref-50">
<label>50</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rafalski</surname><given-names>VA</given-names></name><name><surname>Ho</surname><given-names>PP</given-names></name><name><surname>Brett</surname><given-names>JO</given-names></name><etal></etal></person-group>:
<article-title>Expansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brain.</article-title>
<source/><italic toggle="yes">Nat Cell Biol.</italic>
<year>2013</year>;<volume>15</volume>(<issue>6</issue>):<fpage>614</fpage>–<lpage>24</lpage>.
<pub-id pub-id-type="doi">10.1038/ncb2735</pub-id>
<!--<pub-id pub-id-type="pmcid">4026158</pub-id>-->
<pub-id pub-id-type="pmid">23644469</pub-id></mixed-citation>
</ref>
<ref id="ref-51">
<label>51</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating alpha-tubulin.</article-title>
<source/><italic toggle="yes">J Neurosci.</italic>
<year>2007</year>;<volume>27</volume>(<issue>10</issue>):<fpage>2606</fpage>–<lpage>16</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4181-06.2007</pub-id>
<!--<pub-id pub-id-type="pmcid">6672490</pub-id>-->
<pub-id pub-id-type="pmid">17344398</pub-id></mixed-citation>
</ref>
<ref id="ref-52">
<label>52</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Noack</surname><given-names>M</given-names></name><name><surname>Leyk</surname><given-names>J</given-names></name><name><surname>Richter-Landsberg</surname><given-names>C</given-names></name></person-group>:
<article-title>HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.</article-title>
<source/><italic toggle="yes">Glia.</italic>
<year>2014</year>;<volume>62</volume>(<issue>4</issue>):<fpage>535</fpage>–<lpage>47</lpage>.
<pub-id pub-id-type="doi">10.1002/glia.22624</pub-id>
<pub-id pub-id-type="pmid">24464872</pub-id></mixed-citation>
</ref>
<ref id="ref-53">
<label>53</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>Q</given-names></name><name><surname>D'ercole</surname><given-names>AJ</given-names></name><etal></etal></person-group>:
<article-title>Histone deacetylase 11 regulates oligodendrocyte-specific gene expression and cell development in OL-1 oligodendroglia cells.</article-title>
<source/><italic toggle="yes">Glia.</italic>
<year>2009</year>;<volume>57</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>12</lpage>.
<pub-id pub-id-type="doi">10.1002/glia.20729</pub-id>
<!--<pub-id pub-id-type="pmcid">2595137</pub-id>-->
<pub-id pub-id-type="pmid">18627006</pub-id></mixed-citation>
</ref>
<ref id="ref-54">
<label>54</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Douvaras</surname><given-names>P</given-names></name><name><surname>Rusielewicz</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name><etal></etal></person-group>:
<article-title>Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes.</article-title>
<source/><italic toggle="yes">Int J Mol Sci.</italic>
<year>2016</year>;<volume>17</volume>(<issue>14</issue>): pii: E614.
<pub-id pub-id-type="doi">10.3390/ijms17040614</pub-id>
<!--<pub-id pub-id-type="pmcid">4849063</pub-id>-->
<pub-id pub-id-type="pmid">27110779</pub-id></mixed-citation>
</ref>
<ref id="ref-55">
<label>55</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Behrendt</surname><given-names>G</given-names></name><name><surname>Baer</surname><given-names>K</given-names></name><name><surname>Buffo</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men.</article-title>
<source/><italic toggle="yes">Glia.</italic>
<year>2013</year>;<volume>61</volume>(<issue>2</issue>):<fpage>273</fpage>–<lpage>86</lpage>.
<pub-id pub-id-type="doi">10.1002/glia.22432</pub-id>
<pub-id pub-id-type="pmid">23090919</pub-id></mixed-citation>
</ref>
<ref id="ref-56">
<label>56</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>lncRNA Functional Networks in Oligodendrocytes Reveal Stage-Specific Myelination Control by an
<italic>lncOL1</italic>/Suz12 Complex in the CNS.</article-title>
<source/><italic toggle="yes">Neuron.</italic>
<year>2017</year>;<volume>93</volume>(<issue>2</issue>):<fpage>362</fpage>–<lpage>78</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2016.11.044</pub-id>
<!--<pub-id pub-id-type="pmcid">5600615</pub-id>-->
<pub-id pub-id-type="pmid">28041882</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727161637">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-57">
<label>57</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sher</surname><given-names>F</given-names></name><name><surname>Rössler</surname><given-names>R</given-names></name><name><surname>Brouwer</surname><given-names>N</given-names></name><etal></etal></person-group>:
<article-title>Differentiation of neural stem cells into oligodendrocytes: Involvement of the polycomb group protein Ezh2.</article-title>
<source/><italic toggle="yes">Stem Cells.</italic>
<year>2008</year>;<volume>26</volume>(<issue>11</issue>):<fpage>2875</fpage>–<lpage>83</lpage>.
<pub-id pub-id-type="doi">10.1634/stemcells.2008-0121</pub-id>
<pub-id pub-id-type="pmid">18687996</pub-id></mixed-citation>
</ref>
<ref id="ref-58">
<label>58</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>M</given-names></name><name><surname>Murata</surname><given-names>K</given-names></name><name><surname>Ishida</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Severe Hypomyelination and Developmental Defects Are Caused in Mice Lacking Protein Arginine Methyltransferase 1 (PRMT1) in the Central Nervous System.</article-title>
<source/><italic toggle="yes">J Biol Chem.</italic>
<year>2016</year>;<volume>291</volume>(<issue>5</issue>):<fpage>2237</fpage>–<lpage>45</lpage>.
<pub-id pub-id-type="doi">10.1074/jbc.M115.684514</pub-id>
<!--<pub-id pub-id-type="pmcid">4732207</pub-id>-->
<pub-id pub-id-type="pmid">26637354</pub-id></mixed-citation>
</ref>
<ref id="ref-59">
<label>59</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scaglione</surname><given-names>A</given-names></name><name><surname>Patzig</surname><given-names>J</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>PRMT5-mediated regulation of developmental myelination.</article-title>
<source/><italic toggle="yes">Nat Commun.</italic>
<year>2018</year>;<volume>9</volume>(<issue>1</issue>): 2840.
<pub-id pub-id-type="doi">10.1038/s41467-018-04863-9</pub-id>
<!--<pub-id pub-id-type="pmcid">6053423</pub-id>-->
<pub-id pub-id-type="pmid">30026560</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733672005">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-60">
<label>60</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Calabretta</surname><given-names>S</given-names></name><name><surname>Vogel</surname><given-names>G</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><etal></etal></person-group>:
<article-title>Loss of PRMT5 Promotes PDGFRα Degradation during Oligodendrocyte Differentiation and Myelination.</article-title>
<source/><italic toggle="yes">Dev Cell.</italic>
<year>2018</year>;<volume>46</volume>(<issue>4</issue>):<fpage>426</fpage>–<lpage>440.e5</lpage>.
<pub-id pub-id-type="doi">10.1016/j.devcel.2018.06.025</pub-id>
<pub-id pub-id-type="pmid">30057274</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733693991">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-61">
<label>61</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Vogel</surname><given-names>G</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><etal></etal></person-group>:
<article-title>Type II arginine methyltransferase PRMT5 regulates gene expression of inhibitors of differentiation/DNA binding Id2 and Id4 during glial cell differentiation.</article-title>
<source/><italic toggle="yes">J Biol Chem.</italic>
<year>2011</year>;<volume>286</volume>(<issue>52</issue>):<fpage>44424</fpage>–<lpage>32</lpage>.
<pub-id pub-id-type="doi">10.1074/jbc.M111.277046</pub-id>
<!--<pub-id pub-id-type="pmcid">3247987</pub-id>-->
<pub-id pub-id-type="pmid">22041901</pub-id></mixed-citation>
</ref>
<ref id="ref-62">
<label>62</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moyon</surname><given-names>S</given-names></name><name><surname>Huynh</surname><given-names>JL</given-names></name><name><surname>Dutta</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage.</article-title>
<source/><italic toggle="yes">Cell Rep.</italic>
<year>2016</year>;<volume>15</volume>(<issue>4</issue>):<fpage>748</fpage>–<lpage>60</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2016.03.060</pub-id>
<!--<pub-id pub-id-type="pmcid">5063656</pub-id>-->
<pub-id pub-id-type="pmid">27149841</pub-id></mixed-citation>
</ref>
<ref id="ref-63">
<label>63</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Dai</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>Dynamics of ten-eleven translocation hydroxylase family proteins and 5-hydroxymethylcytosine in oligodendrocyte differentiation.</article-title>
<source/><italic toggle="yes">Glia.</italic>
<year>2014</year>;<volume>62</volume>(<issue>6</issue>):<fpage>914</fpage>–<lpage>26</lpage>.
<pub-id pub-id-type="doi">10.1002/glia.22649</pub-id>
<pub-id pub-id-type="pmid">24615693</pub-id></mixed-citation>
</ref>
<ref id="ref-64">
<label>64</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shin</surname><given-names>D</given-names></name><name><surname>Shin</surname><given-names>JY</given-names></name><name><surname>McManus</surname><given-names>MT</given-names></name><etal></etal></person-group>:
<article-title>Dicer ablation in oligodendrocytes provokes neuronal impairment in mice.</article-title>
<source/><italic toggle="yes">Ann Neurol.</italic>
<year>2009</year>;<volume>66</volume>(<issue>6</issue>):<fpage>843</fpage>–<lpage>57</lpage>.
<pub-id pub-id-type="doi">10.1002/ana.21927</pub-id>
<!--<pub-id pub-id-type="pmcid">2885004</pub-id>-->
<pub-id pub-id-type="pmid">20035504</pub-id></mixed-citation>
</ref>
<ref id="ref-65">
<label>65</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dugas</surname><given-names>JC</given-names></name><name><surname>Cuellar</surname><given-names>TL</given-names></name><name><surname>Scholze</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination.</article-title>
<source/><italic toggle="yes">Neuron.</italic>
<year>2010</year>;<volume>65</volume>(<issue>5</issue>):<fpage>597</fpage>–<lpage>611</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2010.01.027</pub-id>
<!--<pub-id pub-id-type="pmcid">2843397</pub-id>-->
<pub-id pub-id-type="pmid">20223197</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/2555963">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-66">
<label>66</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><etal></etal></person-group>:
<article-title>MicroRNA-Mediated Control of Oligodendrocyte Differentiation.</article-title>
<source/><italic toggle="yes">Neuron.</italic>
<year>2010</year>;<volume>65</volume>(<issue>5</issue>):<fpage>612</fpage>–<lpage>26</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2010.02.018</pub-id>
<!--<pub-id pub-id-type="pmcid">2855245</pub-id>-->
<pub-id pub-id-type="pmid">20223198</pub-id></mixed-citation>
</ref>
<ref id="ref-67">
<label>67</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Moyano</surname><given-names>AL</given-names></name><name><surname>Ma</surname><given-names>Z</given-names></name><etal></etal></person-group>:
<article-title>miR-219 Cooperates with miR-338 in Myelination and Promotes Myelin Repair in the CNS.</article-title>
<source/><italic toggle="yes">Dev Cell.</italic>
<year>2017</year>;<volume>40</volume>(<issue>6</issue>):<fpage>566</fpage>–<lpage>582.e5</lpage>.
<pub-id pub-id-type="doi">10.1016/j.devcel.2017.03.001</pub-id>
<!--<pub-id pub-id-type="pmcid">5569304</pub-id>-->
<pub-id pub-id-type="pmid">28350989</pub-id></mixed-citation>
</ref>
<ref id="ref-68">
<label>68</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>CY</given-names></name><name><surname>Deneen</surname><given-names>B</given-names></name><name><surname>Tzeng</surname><given-names>SF</given-names></name></person-group>:
<article-title>MicroRNA-212 inhibits oligodendrocytes during maturation by down-regulation of differentiation-associated gene expression.</article-title>
<source/><italic toggle="yes">J Neurochem.</italic>
<year>2017</year>;<volume>143</volume>(<issue>1</issue>):<fpage>112</fpage>–<lpage>25</lpage>.
<pub-id pub-id-type="doi">10.1111/jnc.14138</pub-id>
<pub-id pub-id-type="pmid">28771716</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727875324">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-69">
<label>69</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lecca</surname><given-names>D</given-names></name><name><surname>Marangon</surname><given-names>D</given-names></name><name><surname>Coppolino</surname><given-names>GT</given-names></name><etal></etal></person-group>:
<article-title>MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis.</article-title>
<source/><italic toggle="yes">Sci Rep.</italic>
<year>2016</year>;<volume>6</volume>:<fpage>34503</fpage>.
<pub-id pub-id-type="doi">10.1038/srep34503</pub-id>
<!--<pub-id pub-id-type="pmcid">5048305</pub-id>-->
<pub-id pub-id-type="pmid">27698367</pub-id></mixed-citation>
</ref>
<ref id="ref-70">
<label>70</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Cuevas-Diaz Duran</surname><given-names>R</given-names></name><etal></etal></person-group>:
<article-title>Comprehensive Identification of Long Non-coding RNAs in Purified Cell Types from the Brain Reveals Functional LncRNA in OPC Fate Determination.</article-title>
<source/><italic toggle="yes">PLoS Genet.</italic>
<year>2015</year>;<volume>11</volume>(<issue>12</issue>):<fpage>e1005669</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pgen.1005669</pub-id>
<!--<pub-id pub-id-type="pmcid">4980008</pub-id>-->
<pub-id pub-id-type="pmid">26683846</pub-id></mixed-citation>
</ref>
<ref id="ref-71">
<label>71</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kasuga</surname><given-names>Y</given-names></name><name><surname>Fudge</surname><given-names>AD</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>Characterization of a long noncoding RNA Pcdh17it as a novel marker for immature premyelinating oligodendrocytes.</article-title>
<source/><italic toggle="yes">Glia.</italic>
<year>2019</year>;<volume>67</volume>(<issue>11</issue>):<fpage>2166</fpage>–<lpage>77</lpage>.
<pub-id pub-id-type="doi">10.1002/glia.23684</pub-id>
<pub-id pub-id-type="pmid">31328332</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/736231542">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-72">
<label>72</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stolt</surname><given-names>CC</given-names></name><name><surname>Schmitt</surname><given-names>S</given-names></name><name><surname>Lommes</surname><given-names>P</given-names></name><etal></etal></person-group>:
<article-title>Impact of transcription factor Sox8 on oligodendrocyte specification in the mouse embryonic spinal cord.</article-title>
<source/><italic toggle="yes">Dev Biol.</italic>
<year>2005</year>;<volume>281</volume>(<issue>2</issue>):<fpage>309</fpage>–<lpage>17</lpage>.
<pub-id pub-id-type="doi">10.1016/j.ydbio.2005.03.010</pub-id>
<pub-id pub-id-type="pmid">15893981</pub-id></mixed-citation>
</ref>
<ref id="ref-73">
<label>73</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mercer</surname><given-names>TR</given-names></name><name><surname>Qureshi</surname><given-names>IA</given-names></name><name><surname>Gokhan</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Long noncoding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation.</article-title>
<source/><italic toggle="yes">BMC Neurosci.</italic>
<year>2010</year>;<volume>11</volume>:<fpage>14</fpage>.
<pub-id pub-id-type="doi">10.1186/1471-2202-11-14</pub-id>
<!--<pub-id pub-id-type="pmcid">2829031</pub-id>-->
<pub-id pub-id-type="pmid">20137068</pub-id></mixed-citation>
</ref>
<ref id="ref-74">
<label>74</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Katsel</surname><given-names>P</given-names></name><name><surname>Roussos</surname><given-names>P</given-names></name><name><surname>Fam</surname><given-names>P</given-names></name><etal></etal></person-group>:
<article-title>The expression of long noncoding RNA NEAT1 is reduced in schizophrenia and modulates oligodendrocytes transcription.</article-title>
<source/><italic toggle="yes">NPJ Schizophr.</italic>
<year>2019</year>;<volume>5</volume>(<issue>1</issue>):<fpage>1856</fpage>.
<pub-id pub-id-type="doi">10.1038/s41537-019-0071-2</pub-id>
<!--<pub-id pub-id-type="pmcid">6386752</pub-id>-->
<pub-id pub-id-type="pmid">30696826</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/734988509">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-75">
<label>75</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>R</given-names></name><etal></etal></person-group>:
<article-title>A novel long noncoding RNA lnc158 promotes the differentiation of mouse neural precursor cells into oligodendrocytes by targeting nuclear factor-IB.</article-title>
<source/><italic toggle="yes">Neuroreport.</italic>
<year>2018</year>;<volume>29</volume>(<issue>13</issue>):<fpage>1121</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1097/WNR.0000000000001083</pub-id>
<pub-id pub-id-type="pmid">29965871</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733759619">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-76">
<label>76</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Dzhashiashvili</surname><given-names>Y</given-names></name><name><surname>Shah</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>m
<sup>6</sup>A mRNA Methylation Is Essential for Oligodendrocyte Maturation and CNS Myelination.</article-title>
<source/><italic toggle="yes">Neuron.</italic>
<year>2020</year>;<volume>105</volume>(<issue>2</issue>):<fpage>293</fpage>–<lpage>309.e5</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2019.12.013</pub-id>
<pub-id pub-id-type="pmid">31901304</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/737143372">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-77">
<label>77</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><etal></etal></person-group>:
<article-title>A novel m
<sup>6</sup>A reader Prrc2a controls oligodendroglial specification and myelination.</article-title>
<source/><italic toggle="yes">Cell Res.</italic>
<year>2019</year>;<volume>29</volume>(<issue>1</issue>):<fpage>23</fpage>–<lpage>41</lpage>.
<pub-id pub-id-type="doi">10.1038/s41422-018-0113-8</pub-id>
<!--<pub-id pub-id-type="pmcid">6318280</pub-id>-->
<pub-id pub-id-type="pmid">30514900</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/734562286">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-78">
<label>78</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Allis</surname><given-names>CD</given-names></name><name><surname>Jenuwein</surname><given-names>T</given-names></name></person-group>:
<article-title>The molecular hallmarks of epigenetic control.</article-title>
<source/><italic toggle="yes">Nat Rev Genet.</italic>
<year>2016</year>;<volume>17</volume>(<issue>8</issue>):<fpage>487</fpage>–<lpage>500</lpage>.
<pub-id pub-id-type="doi">10.1038/nrg.2016.59</pub-id>
<pub-id pub-id-type="pmid">27346641</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726449204">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-79">
<label>79</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wilson</surname><given-names>BG</given-names></name><name><surname>Roberts</surname><given-names>CWM</given-names></name></person-group>:
<article-title>SWI/SNF nucleosome remodellers and cancer.</article-title>
<source/><italic toggle="yes">Nat Rev Cancer.</italic>
<year>2011</year>;<volume>11</volume>(<issue>7</issue>):<fpage>481</fpage>–<lpage>92</lpage>.
<pub-id pub-id-type="doi">10.1038/nrc3068</pub-id>
<pub-id pub-id-type="pmid">21654818</pub-id></mixed-citation>
</ref>
<ref id="ref-80">
<label>80</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yoo</surname><given-names>AS</given-names></name><name><surname>Crabtree</surname><given-names>GR</given-names></name></person-group>:
<article-title>ATP-dependent chromatin remodeling in neural development.</article-title>
<source/><italic toggle="yes">Curr Opin Neurobiol.</italic>
<year>2009</year>;<volume>19</volume>(<issue>2</issue>):<fpage>120</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1016/j.conb.2009.04.006</pub-id>
<!--<pub-id pub-id-type="pmcid">2756292</pub-id>-->
<pub-id pub-id-type="pmid">19442513</pub-id></mixed-citation>
</ref>
<ref id="ref-81">
<label>81</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>JA</given-names></name><name><surname>Hudson</surname><given-names>LD</given-names></name><name><surname>Armstrong</surname><given-names>RC</given-names></name></person-group>:
<article-title>Nuclear organization in differentiating oligodendrocytes.</article-title>
<source/><italic toggle="yes">J Cell Sci.</italic>
<year>2002</year>;<volume>115</volume>(<issue>Pt 21</issue>):<fpage>4071</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1242/jcs.00103</pub-id>
<pub-id pub-id-type="pmid">12356912</pub-id></mixed-citation>
</ref>
<ref id="ref-82">
<label>82</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Runge</surname><given-names>JS</given-names></name><name><surname>Raab</surname><given-names>JR</given-names></name><name><surname>Magnuson</surname><given-names>T</given-names></name></person-group>:
<article-title>Epigenetic Regulation by ATP-Dependent Chromatin-Remodeling Enzymes: SNF-ing Out Crosstalk.</article-title>
<source/><italic toggle="yes">Curr Top Dev Biol.</italic>
<year>2016</year>;<volume>117</volume>:<fpage>1</fpage>–<lpage>13</lpage>.
<pub-id pub-id-type="doi">10.1016/bs.ctdb.2015.10.009</pub-id>
<!--<pub-id pub-id-type="pmcid">5771231</pub-id>-->
<pub-id pub-id-type="pmid">26969969</pub-id></mixed-citation>
</ref>
<ref id="ref-83">
<label>83</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de La Serna</surname><given-names>IL</given-names></name><name><surname>Ohkawa</surname><given-names>Y</given-names></name><name><surname>Imbalzano</surname><given-names>AN</given-names></name></person-group>:
<article-title>Chromatin remodelling in mammalian differentiation: Lessons from ATP-dependent remodellers.</article-title>
<source/><italic toggle="yes">Nat Rev Genet.</italic>
<year>2006</year>;<volume>7</volume>(<issue>6</issue>):<fpage>461</fpage>–<lpage>73</lpage>.
<pub-id pub-id-type="doi">10.1038/nrg1882</pub-id>
<pub-id pub-id-type="pmid">16708073</pub-id></mixed-citation>
</ref>
<ref id="ref-84">
<label>84</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>S</given-names></name><name><surname>Banine</surname><given-names>F</given-names></name><name><surname>Feistel</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>Brg1 directly regulates Olig2 transcription and is required for oligodendrocyte progenitor cell specification.</article-title>
<source/><italic toggle="yes">Dev Biol.</italic>
<year>2016</year>;<volume>413</volume>(<issue>12</issue>):<fpage>173</fpage>–<lpage>87</lpage>.
<pub-id pub-id-type="doi">10.1016/j.ydbio.2016.04.003</pub-id>
<!--<pub-id pub-id-type="pmcid">4851915</pub-id>-->
<pub-id pub-id-type="pmid">27067865</pub-id></mixed-citation>
</ref>
<ref id="ref-85">
<label>85</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martin</surname><given-names>DM</given-names></name></person-group>:
<article-title>Chromatin remodeling in development and disease: Focus on CHD7.</article-title>
<source/><italic toggle="yes">PLoS Genet.</italic>
<year>2010</year>;<volume>6</volume>(<issue>7</issue>):<fpage>e1001010</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pgen.1001010</pub-id>
<!--<pub-id pub-id-type="pmcid">2904764</pub-id>-->
<pub-id pub-id-type="pmid">20657659</pub-id></mixed-citation>
</ref>
<ref id="ref-86">
<label>86</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bergman</surname><given-names>JEH</given-names></name><name><surname>Janssen</surname><given-names>N</given-names></name><name><surname>Hoefsloot</surname><given-names>LH</given-names></name><etal></etal></person-group>:
<article-title>CHD7 mutations and CHARGE syndrome: The clinical implications of an expanding phenotype.</article-title>
<source/><italic toggle="yes">J Med Genet.</italic>
<year>2011</year>;<volume>48</volume>(<issue>5</issue>):<fpage>334</fpage>–<lpage>42</lpage>.
<pub-id pub-id-type="doi">10.1136/jmg.2010.087106</pub-id>
<pub-id pub-id-type="pmid">21378379</pub-id></mixed-citation>
</ref>
<ref id="ref-87">
<label>87</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stolerman</surname><given-names>ES</given-names></name><name><surname>Smith</surname><given-names>B</given-names></name><name><surname>Chaubey</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>CHD8 intragenic deletion associated with autism spectrum disorder.</article-title>
<source/><italic toggle="yes">Eur J Med Genet.</italic>
<year>2016</year>;<volume>59</volume>(<issue>4</issue>):<fpage>189</fpage>–<lpage>94</lpage>.
<pub-id pub-id-type="doi">10.1016/j.ejmg.2016.02.010</pub-id>
<pub-id pub-id-type="pmid">26921529</pub-id></mixed-citation>
</ref>
<ref id="ref-88">
<label>88</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cotney</surname><given-names>J</given-names></name><name><surname>Muhle</surname><given-names>RA</given-names></name><name><surname>Sanders</surname><given-names>SJ</given-names></name><etal></etal></person-group>:
<article-title>The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment.</article-title>
<source/><italic toggle="yes">Nat Commun.</italic>
<year>2015</year>;<volume>6</volume>:<fpage>6404</fpage>.
<pub-id pub-id-type="doi">10.1038/ncomms7404</pub-id>
<!--<pub-id pub-id-type="pmcid">4355952</pub-id>-->
<pub-id pub-id-type="pmid">25752243</pub-id></mixed-citation>
</ref>
<ref id="ref-89">
<label>89</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Katayama</surname><given-names>Y</given-names></name><name><surname>Nishiyama</surname><given-names>M</given-names></name><name><surname>Shoji</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>CHD8 haploinsufficiency results in autistic-like phenotypes in mice.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2016</year>;<volume>537</volume>(<issue>7622</issue>):<fpage>675</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1038/nature19357</pub-id>
<pub-id pub-id-type="pmid">27602517</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726717214">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-90">
<label>90</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Piunti</surname><given-names>A</given-names></name><name><surname>Shilatifard</surname><given-names>A</given-names></name></person-group>:
<article-title>Epigenetic balance of gene expression by Polycomb and COMPASS families.</article-title>
<source/><italic toggle="yes">Science.</italic>
<year>2016</year>;<volume>352</volume>(<issue>6290</issue>):<fpage>aad9780</fpage>.
<pub-id pub-id-type="doi">10.1126/science.aad9780</pub-id>
<pub-id pub-id-type="pmid">27257261</pub-id></mixed-citation>
</ref>
<ref id="ref-91">
<label>91</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>PB</given-names></name><name><surname>Staller</surname><given-names>P</given-names></name></person-group>:
<article-title>The KDM5 family of histone demethylases as targets in oncology drug discovery.</article-title>
<source/><italic toggle="yes">Epigenomics.</italic>
<year>2014</year>;<volume>6</volume>(<issue>3</issue>):<fpage>277</fpage>–<lpage>86</lpage>.
<pub-id pub-id-type="doi">10.2217/epi.14.14</pub-id>
<pub-id pub-id-type="pmid">25111482</pub-id></mixed-citation>
</ref>
<ref id="ref-92">
<label>92</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moyon</surname><given-names>S</given-names></name><name><surname>Casaccia</surname><given-names>P</given-names></name></person-group>:
<article-title>DNA methylation in oligodendroglial cells during developmental myelination and in disease.</article-title>
<source/><italic toggle="yes">Neurogenesis (Austin).</italic>
<year>2017</year>;<volume>4</volume>(<issue>1</issue>):<fpage>e1270381</fpage>.
<pub-id pub-id-type="doi">10.1080/23262133.2016.1270381</pub-id>
<!--<pub-id pub-id-type="pmcid">5293321</pub-id>-->
<pub-id pub-id-type="pmid">28203606</pub-id></mixed-citation>
</ref>
<ref id="ref-93">
<label>93</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Magri</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><etal></etal></person-group>:
<article-title>Chromatin landscape defined by repressive histone methylation during oligodendrocyte differentiation.</article-title>
<source/><italic toggle="yes">J Neurosci.</italic>
<year>2015</year>;<volume>35</volume>(<issue>1</issue>):<fpage>352</fpage>–<lpage>65</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2606-14.2015</pub-id>
<!--<pub-id pub-id-type="pmcid">4287153</pub-id>-->
<pub-id pub-id-type="pmid">25568127</pub-id></mixed-citation>
</ref>
<ref id="ref-94">
<label>94</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marmorstein</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>MM</given-names></name></person-group>:
<article-title>Writers and Readers of Histone Acetylation: Structure, Mechanism, and Inhibition.</article-title>
<source/><italic toggle="yes">Cold Spring Harb Perspect Biol.</italic>
<year>2014</year>;<volume>6</volume>(<issue>7</issue>):<fpage>a018762</fpage>–<lpage>a018762</lpage>.
<pub-id pub-id-type="doi">10.1101/cshperspect.a018762</pub-id>
<!--<pub-id pub-id-type="pmcid">4067988</pub-id>-->
<pub-id pub-id-type="pmid">24984779</pub-id></mixed-citation>
</ref>
<ref id="ref-95">
<label>95</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raisner</surname><given-names>R</given-names></name><name><surname>Kharbanda</surname><given-names>S</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><etal></etal></person-group>:
<article-title>Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation.</article-title>
<source/><italic toggle="yes">Cell Rep.</italic>
<year>2018</year>;<volume>24</volume>(<issue>7</issue>):<fpage>1722</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2018.07.041</pub-id>
<pub-id pub-id-type="pmid">30110629</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733811885">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-96">
<label>96</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>KK</given-names></name><name><surname>Workman</surname><given-names>JL</given-names></name></person-group>:
<article-title>Histone acetyltransferase complexes: One size doesn't fit all.</article-title>
<source/><italic toggle="yes">Nat Rev Mol Cell Biol.</italic>
<year>2007</year>;<volume>8</volume>(<issue>4</issue>):<fpage>284</fpage>–<lpage>95</lpage>.
<pub-id pub-id-type="doi">10.1038/nrm2145</pub-id>
<pub-id pub-id-type="pmid">17380162</pub-id></mixed-citation>
</ref>
<ref id="ref-97">
<label>97</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roth</surname><given-names>SY</given-names></name><name><surname>Denu</surname><given-names>JM</given-names></name><name><surname>Allis</surname><given-names>CD</given-names></name></person-group>:
<article-title>Histone acetyltransferases.</article-title>
<source/><italic toggle="yes">Annu Rev Biochem.</italic>
<year>2001</year>;<volume>70</volume>:<fpage>81</fpage>–<lpage>120</lpage>.
<pub-id pub-id-type="doi">10.1146/annurev.biochem.70.1.81</pub-id>
<pub-id pub-id-type="pmid">11395403</pub-id></mixed-citation>
</ref>
<ref id="ref-98">
<label>98</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chiang</surname><given-names>DY</given-names></name><name><surname>Kongchan</surname><given-names>N</given-names></name><name><surname>Beavers</surname><given-names>DL</given-names></name><etal></etal></person-group>:
<article-title>Loss of MicroRNA-106b-25 Cluster Promotes Atrial Fibrillation by Enhancing Ryanodine Receptor Type-2 Expression and Calcium Release.</article-title>
<source/><italic toggle="yes">Circ Arrhythm Electrophysiol.</italic>
<year>2014</year>;<volume>7</volume>(<issue>6</issue>):<fpage>1214</fpage>–<lpage>22</lpage>.
<pub-id pub-id-type="doi">10.1161/CIRCEP.114.001973</pub-id>
<!--<pub-id pub-id-type="pmcid">4270890</pub-id>-->
<pub-id pub-id-type="pmid">25389315</pub-id></mixed-citation>
</ref>
<ref id="ref-99">
<label>99</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yun</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Workman</surname><given-names>JL</given-names></name><etal></etal></person-group>:
<article-title>Readers of histone modifications.</article-title>
<source/><italic toggle="yes">Cell Res.</italic>
<year>2011</year>;<volume>21</volume>(<issue>4</issue>):<fpage>564</fpage>–<lpage>78</lpage>.
<pub-id pub-id-type="doi">10.1038/cr.2011.42</pub-id>
<!--<pub-id pub-id-type="pmcid">3131977</pub-id>-->
<pub-id pub-id-type="pmid">21423274</pub-id></mixed-citation>
</ref>
<ref id="ref-100">
<label>100</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gacias</surname><given-names>M</given-names></name><name><surname>Casaccia</surname><given-names>P</given-names></name></person-group>:
<article-title>Epigenetic mechanisms in multiple sclerosis.</article-title>
<source/><italic toggle="yes">Rev Esp Escler Mult.</italic>
<year>2014</year>;<volume>6</volume>(<issue>29</issue>):<fpage>25</fpage>–<lpage>35</lpage>.
<!--<pub-id pub-id-type="pmcid">6107087</pub-id>-->
<pub-id pub-id-type="pmid">30147811</pub-id></mixed-citation>
</ref>
<ref id="ref-101">
<label>101</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><etal></etal></person-group>:
<article-title>Hdac3 Interaction with p300 Histone Acetyltransferase Regulates the Oligodendrocyte and Astrocyte Lineage Fate Switch.</article-title>
<source/><italic toggle="yes">Dev Cell.</italic>
<year>2016</year>;<volume>37</volume>(<issue>6</issue>):<fpage>582</fpage>.
<pub-id pub-id-type="doi">10.1016/j.devcel.2016.06.004</pub-id>
<pub-id pub-id-type="pmid">27326936</pub-id></mixed-citation>
</ref>
<ref id="ref-102">
<label>102</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Glaser</surname><given-names>KB</given-names></name></person-group>:
<article-title>HDAC inhibitors: clinical update and mechanism-based potential.</article-title>
<source/><italic toggle="yes">Biochem Pharmacol.</italic>
<year>2007</year>;<volume>74</volume>(<issue>5</issue>):<fpage>659</fpage>–<lpage>71</lpage>.
<pub-id pub-id-type="doi">10.1016/j.bcp.2007.04.007</pub-id>
<pub-id pub-id-type="pmid">17498667</pub-id></mixed-citation>
</ref>
<ref id="ref-103">
<label>103</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thiagalingam</surname><given-names>S</given-names></name><name><surname>Cheng</surname><given-names>KH</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><etal></etal></person-group>:
<article-title>Histone deacetylases: unique players in shaping the epigenetic histone code.</article-title>
<source/><italic toggle="yes">Ann N Y Acad Sci.</italic>
<year>2003</year>;<volume>983</volume>:<fpage>84</fpage>–<lpage>100</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1749-6632.2003.tb05964.x</pub-id>
<pub-id pub-id-type="pmid">12724214</pub-id></mixed-citation>
</ref>
<ref id="ref-104">
<label>104</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>J</given-names></name><name><surname>Nakashima</surname><given-names>K</given-names></name><name><surname>Kuwabara</surname><given-names>T</given-names></name><etal></etal></person-group>:
<article-title>Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells.</article-title>
<source/><italic toggle="yes">Proc Natl Acad Sci U S A.</italic>
<year>2004</year>;<volume>101</volume>(<issue>47</issue>):<fpage>16659</fpage>–<lpage>64</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.0407643101</pub-id>
<!--<pub-id pub-id-type="pmcid">527137</pub-id>-->
<pub-id pub-id-type="pmid">15537713</pub-id></mixed-citation>
</ref>
<ref id="ref-105">
<label>105</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marin-Husstege</surname><given-names>M</given-names></name><name><surname>Muggironi</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Histone deacetylase activity is necessary for oligodendrocyte lineage progression.</article-title>
<source/><italic toggle="yes">J Neurosci.</italic>
<year>2002</year>;<volume>22</volume>(<issue>23</issue>):<fpage>10333</fpage>–<lpage>45</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-23-10333.2002</pub-id>
<!--<pub-id pub-id-type="pmcid">6758756</pub-id>-->
<pub-id pub-id-type="pmid">12451133</pub-id></mixed-citation>
</ref>
<ref id="ref-106">
<label>106</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shen</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Casaccia-Bonnefil</surname><given-names>P</given-names></name></person-group>:
<article-title>Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain.</article-title>
<source/><italic toggle="yes">J Cell Biol.</italic>
<year>2005</year>;<volume>169</volume>(<issue>4</issue>):<fpage>577</fpage>–<lpage>89</lpage>.
<pub-id pub-id-type="doi">10.1083/jcb.200412101</pub-id>
<!--<pub-id pub-id-type="pmcid">2171688</pub-id>-->
<pub-id pub-id-type="pmid">15897262</pub-id></mixed-citation>
</ref>
<ref id="ref-107">
<label>107</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Sandoval</surname><given-names>J</given-names></name><name><surname>Casaccia-Bonnefil</surname><given-names>P</given-names></name></person-group>:
<article-title>Events at the transition between cell cycle exit and oligodendrocyte progenitor differentiation: the role of HDAC and YY1.</article-title>
<source/><italic toggle="yes">Neuron Glia Biol.</italic>
<year>2007</year>;<volume>3</volume>(<issue>3</issue>):<fpage>221</fpage>–<lpage>31</lpage>.
<pub-id pub-id-type="doi">10.1017/S1740925X08000057</pub-id>
<!--<pub-id pub-id-type="pmcid">2656678</pub-id>-->
<pub-id pub-id-type="pmid">18634613</pub-id></mixed-citation>
</ref>
<ref id="ref-108">
<label>108</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Dupree</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation.</article-title>
<source/><italic toggle="yes">Neuron.</italic>
<year>2007</year>;<volume>55</volume>(<issue>2</issue>):<fpage>217</fpage>–<lpage>30</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2007.06.029</pub-id>
<!--<pub-id pub-id-type="pmcid">2034312</pub-id>-->
<pub-id pub-id-type="pmid">17640524</pub-id></mixed-citation>
</ref>
<ref id="ref-109">
<label>109</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seto</surname><given-names>E</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name></person-group>:
<article-title>Erasers of histone acetylation: the histone deacetylase enzymes.</article-title>
<source/><italic toggle="yes">Cold Spring Harb Perspect Biol.</italic>
<year>2014</year>;<volume>6</volume>(<issue>4</issue>):<fpage>a018713</fpage>–<lpage>a018713</lpage>.
<pub-id pub-id-type="doi">10.1101/cshperspect.a018713</pub-id>
<!--<pub-id pub-id-type="pmcid">3970420</pub-id>-->
<pub-id pub-id-type="pmid">24691964</pub-id></mixed-citation>
</ref>
<ref id="ref-110">
<label>110</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Ozawa</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4.</article-title>
<source/><italic toggle="yes">Genes Dev.</italic>
<year>2005</year>;<volume>19</volume>(<issue>7</issue>):<fpage>827</fpage>–<lpage>39</lpage>.
<pub-id pub-id-type="doi">10.1101/gad.1286005</pub-id>
<!--<pub-id pub-id-type="pmcid">1074320</pub-id>-->
<pub-id pub-id-type="pmid">15805470</pub-id></mixed-citation>
</ref>
<ref id="ref-111">
<label>111</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Tien</surname><given-names>AC</given-names></name><name><surname>Alberta</surname><given-names>JA</given-names></name><etal></etal></person-group>:
<article-title>A Sequentially Priming Phosphorylation Cascade Activates the Gliomagenic Transcription Factor Olig2.</article-title>
<source/><italic toggle="yes">Cell Rep.</italic>
<year>2017</year>;<volume>18</volume>(<issue>13</issue>):<fpage>3167</fpage>–<lpage>77</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2017.03.003</pub-id>
<!--<pub-id pub-id-type="pmcid">5394178</pub-id>-->
<pub-id pub-id-type="pmid">28355568</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727458148">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-112">
<label>112</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guenther</surname><given-names>MG</given-names></name><name><surname>Barak</surname><given-names>O</given-names></name><name><surname>Lazar</surname><given-names>MA</given-names></name></person-group>:
<article-title>The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3.</article-title>
<source/><italic toggle="yes">Mol Cell Biol.</italic>
<year>2001</year>;<volume>21</volume>(<issue>18</issue>):<fpage>6091</fpage>–<lpage>101</lpage>.
<pub-id pub-id-type="doi">10.1128/mcb.21.18.6091-6101.2001</pub-id>
<!--<pub-id pub-id-type="pmcid">87326</pub-id>-->
<pub-id pub-id-type="pmid">11509652</pub-id></mixed-citation>
</ref>
<ref id="ref-113">
<label>113</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hermanson</surname><given-names>O</given-names></name><name><surname>Jepsen</surname><given-names>K</given-names></name><name><surname>Rosenfeld</surname><given-names>MG</given-names></name></person-group>:
<article-title>N-CoR controls differentiation of neural stem cells into astrocytes.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2002</year>;<volume>419</volume>(<issue>6910</issue>):<fpage>934</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1038/nature01156</pub-id>
<pub-id pub-id-type="pmid">12410313</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1010431">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-114">
<label>114</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Greer</surname><given-names>CB</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><etal></etal></person-group>:
<article-title>Histone Deacetylases Positively Regulate Transcription through the Elongation Machinery.</article-title>
<source/><italic toggle="yes">Cell Rep.</italic>
<year>2015</year>;<volume>13</volume>(<issue>7</issue>):<fpage>1444</fpage>–<lpage>55</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2015.10.013</pub-id>
<!--<pub-id pub-id-type="pmcid">4934896</pub-id>-->
<pub-id pub-id-type="pmid">26549458</pub-id></mixed-citation>
</ref>
<ref id="ref-115">
<label>115</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jepsen</surname><given-names>K</given-names></name><name><surname>Hermanson</surname><given-names>O</given-names></name><name><surname>Onami</surname><given-names>TM</given-names></name><etal></etal></person-group>:
<article-title>Combinatorial roles of the nuclear receptor corepressor in transcription and development.</article-title>
<source/><italic toggle="yes">Cell.</italic>
<year>2000</year>;<volume>102</volume>(<issue>6</issue>):<fpage>753</fpage>–<lpage>63</lpage>.
<pub-id pub-id-type="doi">10.1016/s0092-8674(00)00064-7</pub-id>
<pub-id pub-id-type="pmid">11030619</pub-id></mixed-citation>
</ref>
<ref id="ref-116">
<label>116</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>You</surname><given-names>SH</given-names></name><name><surname>Lim</surname><given-names>HW</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><etal></etal></person-group>:
<article-title>Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3
<italic>in vivo</italic>.</article-title>
<source/><italic toggle="yes">Nat Struct Mol Biol.</italic>
<year>2013</year>;<volume>20</volume>(<issue>2</issue>):<fpage>182</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1038/nsmb.2476</pub-id>
<!--<pub-id pub-id-type="pmcid">3565028</pub-id>-->
<pub-id pub-id-type="pmid">23292142</pub-id></mixed-citation>
</ref>
<ref id="ref-117">
<label>117</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fischle</surname><given-names>W</given-names></name><name><surname>Dequiedt</surname><given-names>F</given-names></name><name><surname>Hendzel</surname><given-names>MJ</given-names></name><etal></etal></person-group>:
<article-title>Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR.</article-title>
<source/><italic toggle="yes">Mol Cell.</italic>
<year>2002</year>;<volume>9</volume>(<issue>1</issue>):<fpage>45</fpage>–<lpage>57</lpage>.
<pub-id pub-id-type="doi">10.1016/s1097-2765(01)00429-4</pub-id>
<pub-id pub-id-type="pmid">11804585</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1004628">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-118">
<label>118</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stein</surname><given-names>LR</given-names></name><name><surname>Imai</surname><given-names>S</given-names></name></person-group>:
<article-title>Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging.</article-title>
<source/><italic toggle="yes">EMBO J.</italic>
<year>2014</year>;<volume>33</volume>(<issue>12</issue>):<fpage>1321</fpage>–<lpage>40</lpage>.
<pub-id pub-id-type="doi">10.1002/embj.201386917</pub-id>
<!--<pub-id pub-id-type="pmcid">4194122</pub-id>-->
<pub-id pub-id-type="pmid">24811750</pub-id></mixed-citation>
</ref>
<ref id="ref-119">
<label>119</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dugas</surname><given-names>JC</given-names></name><name><surname>Tai</surname><given-names>YC</given-names></name><name><surname>Speed</surname><given-names>TP</given-names></name><etal></etal></person-group>:
<article-title>Functional genomic analysis of oligodendrocyte differentiation.</article-title>
<source/><italic toggle="yes">J Neurosci.</italic>
<year>2006</year>;<volume>26</volume>(<issue>43</issue>):<fpage>10967</fpage>–<lpage>83</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2572-06.2006</pub-id>
<!--<pub-id pub-id-type="pmcid">6674672</pub-id>-->
<pub-id pub-id-type="pmid">17065439</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1050458">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-120">
<label>120</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ji</surname><given-names>S</given-names></name><name><surname>Doucette</surname><given-names>JR</given-names></name><name><surname>Nazarali</surname><given-names>AJ</given-names></name></person-group>:
<article-title>Sirt2 is a novel
<italic>in vivo</italic> downstream target of Nkx2.2 and enhances oligodendroglial cell differentiation.</article-title>
<source/><italic toggle="yes">J Mol Cell Biol.</italic>
<year>2011</year>;<volume>3</volume>(<issue>6</issue>):<fpage>351</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1093/jmcb/mjr009</pub-id>
<pub-id pub-id-type="pmid">21669943</pub-id></mixed-citation>
</ref>
<ref id="ref-121">
<label>121</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thangaraj</surname><given-names>MP</given-names></name><name><surname>Furber</surname><given-names>KL</given-names></name><name><surname>Gan</surname><given-names>JK</given-names></name><etal></etal></person-group>:
<article-title>RNA-binding Protein Quaking Stabilizes
<italic>Sirt2</italic> mRNA during Oligodendroglial Differentiation.</article-title>
<source/><italic toggle="yes">J Biol Chem.</italic>
<year>2017</year>;<volume>292</volume>(<issue>13</issue>):<fpage>5166</fpage>–<lpage>82</lpage>.
<pub-id pub-id-type="doi">10.1074/jbc.M117.775544</pub-id>
<!--<pub-id pub-id-type="pmcid">5392665</pub-id>-->
<pub-id pub-id-type="pmid">28188285</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727294456">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-122">
<label>122</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>E</given-names></name><etal></etal></person-group>:
<article-title>The QKI-PLP pathway controls SIRT2 abundance in CNS myelin.</article-title>
<source/><italic toggle="yes">Glia.</italic>
<year>2012</year>;<volume>60</volume>(<issue>1</issue>):<fpage>69</fpage>–<lpage>82</lpage>.
<pub-id pub-id-type="doi">10.1002/glia.21248</pub-id>
<!--<pub-id pub-id-type="pmcid">3217119</pub-id>-->
<pub-id pub-id-type="pmid">21948283</pub-id></mixed-citation>
</ref>
<ref id="ref-123">
<label>123</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Haigis</surname><given-names>MC</given-names></name><name><surname>Sinclair</surname><given-names>DA</given-names></name></person-group>:
<article-title>Mammalian sirtuins: biological insights and disease relevance.</article-title>
<source/><italic toggle="yes">Annu Rev Pathol.</italic>
<year>2010</year>;<volume>5</volume>:<fpage>253</fpage>–<lpage>95</lpage>.
<pub-id pub-id-type="doi">10.1146/annurev.pathol.4.110807.092250</pub-id>
<!--<pub-id pub-id-type="pmcid">2866163</pub-id>-->
<pub-id pub-id-type="pmid">20078221</pub-id></mixed-citation>
</ref>
<ref id="ref-124">
<label>124</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Xu</surname><given-names>TY</given-names></name><name><surname>Guan</surname><given-names>YF</given-names></name><etal></etal></person-group>:
<article-title>Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway.</article-title>
<source/><italic toggle="yes">Ann Neurol.</italic>
<year>2011</year>;<volume>69</volume>(<issue>2</issue>):<fpage>360</fpage>–<lpage>74</lpage>.
<pub-id pub-id-type="doi">10.1002/ana.22236</pub-id>
<pub-id pub-id-type="pmid">21246601</pub-id></mixed-citation>
</ref>
<ref id="ref-125">
<label>125</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jablonska</surname><given-names>B</given-names></name><name><surname>Gierdalski</surname><given-names>M</given-names></name><name><surname>Chew</surname><given-names>LJ</given-names></name><etal></etal></person-group>:
<article-title>Sirt1 regulates glial progenitor proliferation and regeneration in white matter after neonatal brain injury.</article-title>
<source/><italic toggle="yes">Nat Commun.</italic>
<year>2016</year>;<volume>7</volume>:<fpage>13866</fpage>.
<pub-id pub-id-type="doi">10.1038/ncomms13866</pub-id>
<!--<pub-id pub-id-type="pmcid">5187440</pub-id>-->
<pub-id pub-id-type="pmid">27991597</pub-id></mixed-citation>
</ref>
<ref id="ref-126">
<label>126</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Werner</surname><given-names>HB</given-names></name><name><surname>Kuhlmann</surname><given-names>K</given-names></name><name><surname>Shen</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Proteolipid protein is required for transport of sirtuin 2 into CNS myelin.</article-title>
<source/><italic toggle="yes">J Neurosci.</italic>
<year>2007</year>;<volume>27</volume>(<issue>29</issue>):<fpage>7717</fpage>–<lpage>30</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1254-07.2007</pub-id>
<!--<pub-id pub-id-type="pmcid">2676101</pub-id>-->
<pub-id pub-id-type="pmid">17634366</pub-id></mixed-citation>
</ref>
<ref id="ref-127">
<label>127</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heintzman</surname><given-names>ND</given-names></name><name><surname>Stuart</surname><given-names>RK</given-names></name><name><surname>Hon</surname><given-names>G</given-names></name><etal></etal></person-group>:
<article-title>Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.</article-title>
<source/><italic toggle="yes">Nat Genet.</italic>
<year>2007</year>;<volume>39</volume>(<issue>3</issue>):<fpage>311</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1038/ng1966</pub-id>
<pub-id pub-id-type="pmid">17277777</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1074755">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-128">
<label>128</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schneider</surname><given-names>J</given-names></name><name><surname>Wood</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><etal></etal></person-group>:
<article-title>Molecular regulation of histone H3 trimethylation by COMPASS and the regulation of gene expression.</article-title>
<source/><italic toggle="yes">Mol Cell.</italic>
<year>2005</year>;<volume>19</volume>(<issue>6</issue>):<fpage>849</fpage>–<lpage>56</lpage>.
<pub-id pub-id-type="doi">10.1016/j.molcel.2005.07.024</pub-id>
<pub-id pub-id-type="pmid">16168379</pub-id></mixed-citation>
</ref>
<ref id="ref-129">
<label>129</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miller</surname><given-names>T</given-names></name><name><surname>Krogan</surname><given-names>NJ</given-names></name><name><surname>Dover</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>COMPASS: a complex of proteins associated with a trithorax-related SET domain protein.</article-title>
<source/><italic toggle="yes">Proc Natl Acad Sci U S A.</italic>
<year>2001</year>;<volume>98</volume>(<issue>23</issue>):<fpage>12902</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.231473398</pub-id>
<!--<pub-id pub-id-type="pmcid">60797</pub-id>-->
<pub-id pub-id-type="pmid">11687631</pub-id></mixed-citation>
</ref>
<ref id="ref-130">
<label>130</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mohn</surname><given-names>F</given-names></name><name><surname>Weber</surname><given-names>M</given-names></name><name><surname>Rebhan</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Lineage-specific polycomb targets and
<italic>de novo</italic> DNA methylation define restriction and potential of neuronal progenitors.</article-title>
<source/><italic toggle="yes">Mol Cell.</italic>
<year>2008</year>;<volume>30</volume>(<issue>6</issue>):<fpage>755</fpage>–<lpage>66</lpage>.
<pub-id pub-id-type="doi">10.1016/j.molcel.2008.05.007</pub-id>
<pub-id pub-id-type="pmid">18514006</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1124448">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-131">
<label>131</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mikkelsen</surname><given-names>TS</given-names></name><name><surname>Ku</surname><given-names>M</given-names></name><name><surname>Jaffe</surname><given-names>DB</given-names></name><etal></etal></person-group>:
<article-title>Genome-wide maps of chromatin state in pluripotent and lineage-committed cells.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2007</year>;<volume>448</volume>(<issue>7153</issue>):<fpage>553</fpage>–<lpage>60</lpage>.
<pub-id pub-id-type="doi">10.1038/nature06008</pub-id>
<!--<pub-id pub-id-type="pmcid">2921165</pub-id>-->
<pub-id pub-id-type="pmid">17603471</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1089729">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-132">
<label>132</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cao</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>Role of histone H3 lysine 27 methylation in Polycomb-group silencing.</article-title>
<source/><italic toggle="yes">Science.</italic>
<year>2002</year>;<volume>298</volume>(<issue>5595</issue>):<fpage>1039</fpage>–<lpage>43</lpage>.
<pub-id pub-id-type="doi">10.1126/science.1076997</pub-id>
<pub-id pub-id-type="pmid">12351676</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1010608">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-133">
<label>133</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Laugesen</surname><given-names>A</given-names></name><name><surname>Højfeldt</surname><given-names>JW</given-names></name><name><surname>Helin</surname><given-names>K</given-names></name></person-group>:
<article-title>Molecular Mechanisms Directing PRC2 Recruitment and H3K27 Methylation.</article-title>
<source/><italic toggle="yes">Mol Cell.</italic>
<year>2019</year>;<volume>74</volume>(<issue>1</issue>):<fpage>8</fpage>–<lpage>18</lpage>.
<pub-id pub-id-type="doi">10.1016/j.molcel.2019.03.011</pub-id>
<!--<pub-id pub-id-type="pmcid">6452890</pub-id>-->
<pub-id pub-id-type="pmid">30951652</pub-id></mixed-citation>
</ref>
<ref id="ref-134">
<label>134</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>JR</given-names></name><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Oksuz</surname><given-names>O</given-names></name><etal></etal></person-group>:
<article-title>PRC2 is high maintenance.</article-title>
<source/><italic toggle="yes">Genes Dev.</italic>
<year>2019</year>;<volume>33</volume>(<issue>15–16</issue>):<fpage>903</fpage>–<lpage>35</lpage>.
<pub-id pub-id-type="doi">10.1101/gad.325050.119</pub-id>
<!--<pub-id pub-id-type="pmcid">6672058</pub-id>-->
<pub-id pub-id-type="pmid">31123062</pub-id></mixed-citation>
</ref>
<ref id="ref-135">
<label>135</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ai</surname><given-names>S</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><etal></etal></person-group>:
<article-title>EED orchestration of heart maturation through interaction with HDACs is H3K27me3-independent.</article-title>
<source/><italic toggle="yes">eLife.</italic>
<year>2017</year>;<volume>6</volume>: pii: e24570.
<pub-id pub-id-type="doi">10.7554/eLife.24570</pub-id>
<!--<pub-id pub-id-type="pmcid">5400508</pub-id>-->
<pub-id pub-id-type="pmid">28394251</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727493777">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-136">
<label>136</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Margueron</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Sarma</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms.</article-title>
<source/><italic toggle="yes">Mol Cell.</italic>
<year>2008</year>;<volume>32</volume>(<issue>4</issue>):<fpage>503</fpage>–<lpage>18</lpage>.
<pub-id pub-id-type="doi">10.1016/j.molcel.2008.11.004</pub-id>
<!--<pub-id pub-id-type="pmcid">3641558</pub-id>-->
<pub-id pub-id-type="pmid">19026781</pub-id></mixed-citation>
</ref>
<ref id="ref-137">
<label>137</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Jones</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Somatic mutations of
<italic>SUZ12</italic> in malignant peripheral nerve sheath tumors.</article-title>
<source/><italic toggle="yes">Nat Genet.</italic>
<year>2014</year>;<volume>46</volume>(<issue>11</issue>):<fpage>1170</fpage>–<lpage>2</lpage>.
<pub-id pub-id-type="doi">10.1038/ng.3116</pub-id>
<!--<pub-id pub-id-type="pmcid">4383254</pub-id>-->
<pub-id pub-id-type="pmid">25305755</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725297339">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-138">
<label>138</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lewis</surname><given-names>PW</given-names></name><name><surname>Muller</surname><given-names>MM</given-names></name><name><surname>Koletsky</surname><given-names>MS</given-names></name><etal></etal></person-group>:
<article-title>Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma.</article-title>
<source/><italic toggle="yes">Science.</italic>
<year>2013</year>;<volume>340</volume>(<issue>6134</issue>):<fpage>857</fpage>–<lpage>61</lpage>.
<pub-id pub-id-type="doi">10.1126/science.1232245</pub-id>
<!--<pub-id pub-id-type="pmcid">3951439</pub-id>-->
<pub-id pub-id-type="pmid">23539183</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718001918">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-139">
<label>139</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bender</surname><given-names>S</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Lindroth</surname><given-names>AM</given-names></name><etal></etal></person-group>:
<article-title>Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas.</article-title>
<source/><italic toggle="yes">Cancer Cell.</italic>
<year>2013</year>;<volume>24</volume>(<issue>5</issue>):<fpage>660</fpage>–<lpage>72</lpage>.
<pub-id pub-id-type="doi">10.1016/j.ccr.2013.10.006</pub-id>
<pub-id pub-id-type="pmid">24183680</pub-id></mixed-citation>
</ref>
<ref id="ref-140">
<label>140</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Larson</surname><given-names>JD</given-names></name><name><surname>Kasper</surname><given-names>LH</given-names></name><name><surname>Paugh</surname><given-names>BS</given-names></name><etal></etal></person-group>:
<article-title>Histone H3.3 K27M Accelerates Spontaneous Brainstem Glioma and Drives Restricted Changes in Bivalent Gene Expression.</article-title>
<source/><italic toggle="yes">Cancer Cell.</italic>
<year>2019</year>;<volume>35</volume>(<issue>1</issue>):<fpage>140</fpage>–<lpage>155.e7</lpage>.
<pub-id pub-id-type="doi">10.1016/j.ccell.2018.11.015</pub-id>
<!--<pub-id pub-id-type="pmcid">6570409</pub-id>-->
<pub-id pub-id-type="pmid">30595505</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/734701180">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-141">
<label>141</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Roberts</surname><given-names>CW</given-names></name></person-group>:
<article-title>Targeting EZH2 in cancer.</article-title>
<source/><italic toggle="yes">Nat Med.</italic>
<year>2016</year>;<volume>22</volume>(<issue>2</issue>):<fpage>128</fpage>–<lpage>34</lpage>.
<pub-id pub-id-type="doi">10.1038/nm.4036</pub-id>
<!--<pub-id pub-id-type="pmcid">4918227</pub-id>-->
<pub-id pub-id-type="pmid">26845405</pub-id></mixed-citation>
</ref>
<ref id="ref-142">
<label>142</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Filbin</surname><given-names>MG</given-names></name><name><surname>Tirosh</surname><given-names>I</given-names></name><name><surname>Hovestadt</surname><given-names>V</given-names></name><etal></etal></person-group>:
<article-title>Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq.</article-title>
<source/><italic toggle="yes">Science.</italic>
<year>2018</year>;<volume>360</volume>(<issue>6386</issue>):<fpage>331</fpage>–<lpage>5</lpage>.
<pub-id pub-id-type="doi">10.1126/science.aao4750</pub-id>
<!--<pub-id pub-id-type="pmcid">5949869</pub-id>-->
<pub-id pub-id-type="pmid">29674595</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733078339">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-143">
<label>143</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weng</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Single-Cell Transcriptomics Uncovers Glial Progenitor Diversity and Cell Fate Determinants during Development and Gliomagenesis.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2019</year>;<volume>24</volume>(<issue>5</issue>):<fpage>707</fpage>–<lpage>723.e8</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2019.03.006</pub-id>
<!--<pub-id pub-id-type="pmcid">6669001</pub-id>-->
<pub-id pub-id-type="pmid">30982771</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/735532210">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-144">
<label>144</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bedford</surname><given-names>MT</given-names></name></person-group>:
<article-title>Arginine methylation at a glance.</article-title>
<source/><italic toggle="yes">J Cell Sci.</italic>
<year>2007</year>;<volume>120</volume>(<issue>Pt 24</issue>):<fpage>4243</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1242/jcs.019885</pub-id>
<pub-id pub-id-type="pmid">18057026</pub-id></mixed-citation>
</ref>
<ref id="ref-145">
<label>145</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saxonov</surname><given-names>S</given-names></name><name><surname>Berg</surname><given-names>P</given-names></name><name><surname>Brutlag</surname><given-names>DL</given-names></name></person-group>:
<article-title>A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters.</article-title>
<source/><italic toggle="yes">Proc Natl Acad Sci U S A.</italic>
<year>2006</year>;<volume>103</volume>(<issue>5</issue>):<fpage>1412</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.0510310103</pub-id>
<!--<pub-id pub-id-type="pmcid">1345710</pub-id>-->
<pub-id pub-id-type="pmid">16432200</pub-id></mixed-citation>
</ref>
<ref id="ref-146">
<label>146</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kohli</surname><given-names>RM</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group>:
<article-title>TET enzymes, TDG and the dynamics of DNA demethylation.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2013</year>;<volume>502</volume>(<issue>7472</issue>):<fpage>472</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1038/nature12750</pub-id>
<!--<pub-id pub-id-type="pmcid">4046508</pub-id>-->
<pub-id pub-id-type="pmid">24153300</pub-id></mixed-citation>
</ref>
<ref id="ref-147">
<label>147</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moyon</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>D</given-names></name><name><surname>Huynh</surname><given-names>JL</given-names></name><etal></etal></person-group>:
<article-title>Efficient Remyelination Requires DNA Methylation.</article-title>
<source/><italic toggle="yes">eNeuro.</italic>
<year>2017</year>;<volume>4</volume>(<issue>2</issue>): pii: ENEURO.0336-16.2017.
<pub-id pub-id-type="doi">10.1523/ENEURO.0336-16.2017</pub-id>
<!--<pub-id pub-id-type="pmcid">5394940</pub-id>-->
<pub-id pub-id-type="pmid">28451635</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727563012">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-148">
<label>148</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moyon</surname><given-names>S</given-names></name><name><surname>Frawley</surname><given-names>R</given-names></name><name><surname>Marshall-Phelps</surname><given-names>KL</given-names></name><etal></etal></person-group>:
<article-title>TET1-mediated DNA hydroxy-methylation regulates adult remyelination.</article-title>
<source/><italic toggle="yes">bioRxiv.</italic>
<year>2019</year>; 819995.
<pub-id pub-id-type="doi">10.1101/819995</pub-id>
</mixed-citation>
</ref>
<ref id="ref-149">
<label>149</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>TET1-mediated Oligodendrocyte Homeostasis Regulates Myelination and Synaptic Functions.</article-title>
<source/><italic toggle="yes">bioRxiv.</italic>
<year>2019</year>; 821496.
<pub-id pub-id-type="doi">10.1101/821496</pub-id>
</mixed-citation>
</ref>
<ref id="ref-150">
<label>150</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lau</surname><given-names>P</given-names></name><name><surname>Verrier</surname><given-names>JD</given-names></name><name><surname>Nielsen</surname><given-names>JA</given-names></name><etal></etal></person-group>:
<article-title>Identification of Dynamically Regulated MicroRNA and mRNA Networks in Developing Oligodendrocytes.</article-title>
<source/><italic toggle="yes">J Neurosci.</italic>
<year>2008</year>;<volume>28</volume>(<issue>45</issue>):<fpage>11720</fpage>–<lpage>30</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1932-08.2008</pub-id>
<!--<pub-id pub-id-type="pmcid">2646797</pub-id>-->
<pub-id pub-id-type="pmid">18987208</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1158729">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-151">
<label>151</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hudish</surname><given-names>LI</given-names></name><name><surname>Blasky</surname><given-names>AJ</given-names></name><name><surname>Appel</surname><given-names>B</given-names></name></person-group>:
<article-title>miR-219 Regulates Neural Precursor Differentiation by Direct Inhibition of Apical Par Polarity Proteins.</article-title>
<source/><italic toggle="yes">Dev Cell.</italic>
<year>2013</year>;<volume>27</volume>(<issue>4</issue>):<fpage>387</fpage>–<lpage>98</lpage>.
<pub-id pub-id-type="doi">10.1016/j.devcel.2013.10.015</pub-id>
<!--<pub-id pub-id-type="pmcid">3862977</pub-id>-->
<pub-id pub-id-type="pmid">24239515</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718178589">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-152">
<label>152</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Galloway</surname><given-names>DA</given-names></name><name><surname>Moore</surname><given-names>CS</given-names></name></person-group>:
<article-title>miRNAs As Emerging Regulators of Oligodendrocyte Development and Differentiation.</article-title>
<source/><italic toggle="yes">Front Cell Dev Biol.</italic>
<year>2016</year>;<volume>4</volume>:<fpage>59</fpage>.
<pub-id pub-id-type="doi">10.3389/fcell.2016.00059</pub-id>
<!--<pub-id pub-id-type="pmcid">4911355</pub-id>-->
<pub-id pub-id-type="pmid">27379236</pub-id></mixed-citation>
</ref>
<ref id="ref-153">
<label>153</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>A</given-names></name><name><surname>Volsko</surname><given-names>C</given-names></name><name><surname>Garcia</surname><given-names>JP</given-names></name><etal></etal></person-group>:
<article-title>Oligodendrocyte Intrinsic miR-27a Controls Myelination and Remyelination.</article-title>
<source/><italic toggle="yes">Cell Rep.</italic>
<year>2019</year>;<volume>29</volume>(<issue>4</issue>):<fpage>904</fpage>–<lpage>919.e9</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2019.09.020</pub-id>
<!--<pub-id pub-id-type="pmcid">6874400</pub-id>-->
<pub-id pub-id-type="pmid">31644912</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/736795216">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-154">
<label>154</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guttman</surname><given-names>M</given-names></name><name><surname>Amit</surname><given-names>I</given-names></name><name><surname>Garber</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2009</year>;<volume>458</volume>(<issue>7235</issue>):<fpage>223</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1038/nature07672</pub-id>
<!--<pub-id pub-id-type="pmcid">2754849</pub-id>-->
<pub-id pub-id-type="pmid">19182780</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1158132">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-155">
<label>155</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Batista</surname><given-names>PJ</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name></person-group>:
<article-title>Long noncoding RNAs: cellular address codes in development and disease.</article-title>
<source/><italic toggle="yes">Cell.</italic>
<year>2013</year>;<volume>152</volume>(<issue>6</issue>):<fpage>1298</fpage>–<lpage>307</lpage>.
<pub-id pub-id-type="doi">10.1016/j.cell.2013.02.012</pub-id>
<!--<pub-id pub-id-type="pmcid">3651923</pub-id>-->
<pub-id pub-id-type="pmid">23498938</pub-id></mixed-citation>
</ref>
<ref id="ref-156">
<label>156</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatica</surname><given-names>A</given-names></name><name><surname>Bozzoni</surname><given-names>I</given-names></name></person-group>:
<article-title>Long non-coding RNAs: new players in cell differentiation and development.</article-title>
<source/><italic toggle="yes">Nat Rev Genet.</italic>
<year>2014</year>;<volume>15</volume>(<issue>1</issue>):<fpage>7</fpage>–<lpage>21</lpage>.
<pub-id pub-id-type="doi">10.1038/nrg3606</pub-id>
<pub-id pub-id-type="pmid">24296535</pub-id></mixed-citation>
</ref>
<ref id="ref-157">
<label>157</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bhan</surname><given-names>A</given-names></name><name><surname>Mandal</surname><given-names>SS</given-names></name></person-group>:
<article-title>Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease.</article-title>
<source/><italic toggle="yes">ChemMedChem.</italic>
<year>2014</year>;<volume>9</volume>(<issue>9</issue>):<fpage>1932</fpage>–<lpage>56</lpage>.
<pub-id pub-id-type="doi">10.1002/cmdc.201300534</pub-id>
<pub-id pub-id-type="pmid">24677606</pub-id></mixed-citation>
</ref>
<ref id="ref-158">
<label>158</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lalevée</surname><given-names>S</given-names></name><name><surname>Feil</surname><given-names>R</given-names></name></person-group>:
<article-title>Long noncoding RNAs in human disease: emerging mechanisms and therapeutic strategies.</article-title>
<source/><italic toggle="yes">Epigenomics.</italic>
<year>2015</year>;<volume>7</volume>(<issue>6</issue>):<fpage>877</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.2217/epi.15.55</pub-id>
<pub-id pub-id-type="pmid">26418705</pub-id></mixed-citation>
</ref>
<ref id="ref-159">
<label>159</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Yue</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>A METTL3-METTL14 complex mediates mammalian nuclear RNA
<italic>N</italic>
<sup>6</sup>-adenosine methylation.</article-title>
<source/><italic toggle="yes">Nat Chem Biol.</italic>
<year>2014</year>;<volume>10</volume>(<issue>2</issue>):<fpage>93</fpage>–<lpage>5</lpage>.
<pub-id pub-id-type="doi">10.1038/nchembio.1432</pub-id>
<!--<pub-id pub-id-type="pmcid">3911877</pub-id>-->
<pub-id pub-id-type="pmid">24316715</pub-id></mixed-citation>
</ref>
<ref id="ref-160">
<label>160</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Dominissini</surname><given-names>D</given-names></name><name><surname>Rechavi</surname><given-names>G</given-names></name><etal></etal></person-group>:
<article-title>Gene expression regulation mediated through reversible m
<sup>6</sup>A RNA methylation.</article-title>
<source/><italic toggle="yes">Nat Rev Genet.</italic>
<year>2014</year>;<volume>15</volume>(<issue>5</issue>):<fpage>293</fpage>–<lpage>306</lpage>.
<pub-id pub-id-type="doi">10.1038/nrg3724</pub-id>
<pub-id pub-id-type="pmid">24662220</pub-id></mixed-citation>
</ref>
<ref id="ref-161">
<label>161</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ji</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>N</given-names></name><etal></etal></person-group>:
<article-title>N6-Methyladenosine in RNA and DNA: An Epitranscriptomic and Epigenetic Player Implicated in Determination of Stem Cell Fate.</article-title>
<source/><italic toggle="yes">Stem Cells Int.</italic>
<year>2018</year>;<volume>2018</volume>: 3256524.
<pub-id pub-id-type="doi">10.1155/2018/3256524</pub-id>
<!--<pub-id pub-id-type="pmcid">6199872</pub-id>-->
<pub-id pub-id-type="pmid">30405719</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/734406241">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-162">
<label>162</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tse</surname><given-names>KH</given-names></name><name><surname>Cheng</surname><given-names>A</given-names></name><name><surname>Ma</surname><given-names>F</given-names></name><etal></etal></person-group>:
<article-title>DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia.</article-title>
<source/><italic toggle="yes">Alzheimers Dement.</italic>
<year>2018</year>;<volume>14</volume>(<issue>5</issue>):<fpage>664</fpage>–<lpage>79</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jalz.2017.11.010</pub-id>
<!--<pub-id pub-id-type="pmcid">5938117</pub-id>-->
<pub-id pub-id-type="pmid">29328926</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/732451781">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-163">
<label>163</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mathys</surname><given-names>H</given-names></name><name><surname>Davila-Velderrain</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>Z</given-names></name><etal></etal></person-group>:
<article-title>Single-cell transcriptomic analysis of Alzheimer’s disease.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2019</year>;<volume>570</volume>(<issue>7761</issue>):<fpage>332</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1038/s41586-019-1195-2</pub-id>
<!--<pub-id pub-id-type="pmcid">6865822</pub-id>-->
<pub-id pub-id-type="pmid">31042697</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/735645480">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>